var title_f31_60_32704="FIBSER";
var content_f31_60_32704=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PSYCH%2F76881&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PSYCH%2F76881&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 629px\">",
"   <div class=\"ttl\">",
"    Frequency, Intensity, and Burden of Side Effects Ratings (FIBSER)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 609px; height: 449px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    NOTE: The FIBSER is in the public domain. It may be copied and used without permission.",
"    <div class=\"footnotes\">",
"     %: percent.",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced from: Wisniewski, SR, Rush, AJ, Balasubramani, GK, et al. Self-rated global meaure of the frequency, intensity, and burden of side effects. J Psychiatr Pract 2006; 12:71.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_60_32704=[""].join("\n");
var outline_f31_60_32704=null;
var title_f31_60_32705="Left posterior fascicular block";
var content_f31_60_32705=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F51923&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F51923&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Left posterior fascicular block",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 364px; height: 127px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A negative QRS complex in lead I and positive QRS complex in aVF is characteristic of a left posterior hemiblock. The QRS duration is normal.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_60_32705=[""].join("\n");
var outline_f31_60_32705=null;
var title_f31_60_32706="Incontinentia pigmenti 2";
var content_f31_60_32706=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F78272&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F78272&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Incontinentia pigmenti",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Crops of erythematous papules and vesicles distributed in linear streaks along the Blasko lines in a female neonate with incontinentia pigmenti.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_60_32706=[""].join("\n");
var outline_f31_60_32706=null;
var title_f31_60_32707="SCCA left vestibule";
var content_f31_60_32707=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F71971&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F71971&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 553px\">",
"   <div class=\"ttl\">",
"    SCCA of the left vestibule",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 533px; height: 228px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    SCCA of the left vestibule (A) that extended through the septum into the right vestibule (B).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Parsons JT, Stringer SP, Mancuso AA, Million RR. Nasal vestibule, nasal cavity, and paranasal sinuses. In: Million RR, Cassisi NJ (Eds). Management of Head and Neck Cancer: A Multidisciplinary Approach. Philadelphia: J.B. Lippincott Company, 1994. Copyright &copy; 1994 Lippincott Williams &amp; Wilkins.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.lww.com\">",
"      file://www.lww.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_60_32707=[""].join("\n");
var outline_f31_60_32707=null;
var title_f31_60_32708="Urofollitropin (purified human follicle stimulating hormone): Drug information";
var content_f31_60_32708=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Urofollitropin (purified human follicle stimulating hormone): Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"mobipreview.htm?28/1/28692?source=see_link\">",
"    see \"Urofollitropin (purified human follicle stimulating hormone): Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F3878204\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Bravelle&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F248402\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Bravelle&reg;;",
"     </li>",
"     <li>",
"      Fertinorm&reg; H.P.",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F5032785\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Gonadotropin;",
"     </li>",
"     <li>",
"      Ovulation Stimulator",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F3878217\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Note:",
"     </b>",
"     Dose should be individualized. Use the lowest dose consistent with the expectation of good results. Over the course of treatment, doses may vary depending on individual patient response.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Females:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <b>",
"      Ovulation induction:",
"     </b>",
"     I.M., SubQ: Initial: 150 units daily for the first 5 days of treatment. Dose adjustments &le;75-150 units can be made every &ge;2 days; maximum daily dose: 450 units; treatment &gt;12 days is not recommended. If response to follitropin is appropriate, hCG is given 1 day following the last dose. Withhold hCG if serum estradiol is &gt;2000 pg/mL, if the ovaries are abnormally enlarged, or if abdominal pain occurs.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <b>",
"      ART:",
"     </b>",
"     SubQ: 225 units daily for the first 5 days; dose may be adjusted based on patient response, but adjustments should not be made more frequently than once every 2 days; maximum adjustment: 75-150 units; maximum daily dose: 450 units; maximum duration of treatment: 12 days. When a sufficient number of follicles of adequate size are present, the final maturation of the follicles is induced by administering hCG. Withhold hCG in cases where the ovaries are abnormally enlarged on the last day of therapy.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F248395\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, powder for reconstitution [human origin]:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Bravelle&reg;: 75 units [contains lactose 23 mg]",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F248397\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Administer I.M. or SubQ; gently massage site after administration.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     I.M.: Administer in upper quadrant of buttock near hip",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     SubQ: Administer on lower abdomen; thigh is not recommended unless abdomen cannot be used",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F248396\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Ovulation induction in patients who previously received pituitary suppression; development of multiple follicles with Assisted Reproductive Technologies (ART)",
"    </p>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F3878210\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Percentage may vary by indication, route of administration.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     &gt;10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Central nervous system: Headache",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Endocrine &amp; metabolic: Ovarian enlargement, ovarian hyperstimulation syndrome",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Gastrointestinal: Abdominal cramps",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     1% to 10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Cardiovascular: Hypertension",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Central nervous system: Depression, emotional lability, fever, pain",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Dermatologic: Acne, exfoliative dermatitis, rash",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Endocrine &amp; metabolic: Breast tenderness, hot flashes, ovarian disorder (pain, cyst)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Gastrointestinal: Abdomen enlarged, abdominal pain, constipation, diarrhea, dehydration, nausea, vomiting, weight gain",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Genitourinary: Cervical disorder, urinary tract infection, pelvic pain/cramps, uterine spasms, vaginal discharge, vaginal hemorrhage, vaginal spotting",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Local: Injection site reaction",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Neck pain",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Respiratory: Respiratory disorder, sinusitis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Miscellaneous: Infection, postretrieval pain",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Postmarketing, case reports, or events reported with gonadotropins: Acute respiratory distress syndrome, adnexal torsion, anaphylactic reactions,  arterial occlusion, atelectasis, cerebral vascular occlusion, deep vein thrombosis, hemoperitoneum, hypersensitivity reactions, ovarian neoplasms, pulmonary embolism",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F248400\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to follitropins or any component of the formulation; high levels of FSH indicating primary ovarian failure; uncontrolled thyroid or adrenal dysfunction; the presence of any cause of infertility other than anovulation; presence of an organic intracranial lesion (eg, pituitary tumor); abnormal vaginal bleeding of undetermined origin; ovarian cysts or enlargement not due to polycystic ovary syndrome; pregnancy",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F248385\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Ovarian enlargement: May be accompanied by abdominal distention or abdominal pain, occurs in ~20% of those treated with urofollitropin and hCG, and generally regresses without treatment within 2-3 weeks. If ovaries are abnormally enlarged on the last day of treatment, withhold hCG to reduce the risk of ovarian hyperstimulation syndrome (OHSS).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Ovarian hyperstimulation syndrome (OHSS): OHSS is characterized by severe ovarian enlargement, abdominal pain/distention, nausea, vomiting, diarrhea, dyspnea, and oliguria, and may be accompanied by ascites, pleural effusion, hypovolemia, electrolyte imbalance, hemoperitoneum, and thromboembolic events. If hyperstimulation occurs, stop treatment and hospitalize patient. This syndrome develops rapidly within 24 hours to several days and generally occurs during the 7-10 days immediately following treatment. Hemoconcentration associated with fluid loss into the abdominal cavity has occurred and should be assessed by fluid intake and output, weight, hematocrit, serum and urinary electrolytes, urine specific gravity, BUN and creatinine, and abdominal girth. Determinations should be performed daily or more often if the need arises. Treatment is primarily symptomatic and consists of bedrest, fluid and electrolyte replacement, and analgesics. The ascitic, pleural, and pericardial fluids should not be removed unless needed to relieve symptoms of cardiopulmonary distress.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Pulmonary effects: Serious pulmonary conditions (atelectasis, acute respiratory distress syndrome, and exacerbation of asthma) have been reported.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Thromboembolic events: In association with and separate from ovarian hyperstimulation syndrome (OHSS), thromboembolic events have been reported.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Special populations:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Elderly: Safety and efficacy have not been established in the elderly.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Pediatrics: Safety and efficacy have not been established in children.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Dosage form specific issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Lactose: Products may contain lactose.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Other warnings/precautions:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Appropriate use: To minimize risks, use only at the lowest effective dose. Monitor ovarian response with serum estradiol and vaginal ultrasound on a regular basis.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Experienced physician: These medications should only be used by physicians who are thoroughly familiar with infertility problems and their management.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Multiple births: May result from the use of these medications; advise patient of the potential risk of multiple births before starting the treatment.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13300197\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F6223598\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:0em;display:inline\">",
"     There are no known significant interactions.",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F248391\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     X (",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F3878205\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Ectopic pregnancy, congenital abnormalities, spontaneous abortion, and multiple births have been reported. The incidence of congenital abnormality may be slightly higher after ART than with spontaneous conception; higher incidence may be related to parenteral characteristics (maternal age, sperm characteristics).",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F3878207\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excretion in breast milk unknown/not recommended",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F16324119\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution (reconstituted)",
"     </b>",
"     (Bravelle Injection)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     75 unit (1): $118.15",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F3878220\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Monitor sufficient follicular maturation. This may be directly estimated by sonographic visualization of the ovaries and endometrial lining or measuring serum estradiol levels. The combination of both ultrasonography and measurement of estradiol levels is useful for monitoring for the growth and development of follicles and timing hCG administration.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;text-align:justify;\">",
"     The clinical evaluation of estrogenic activity (changes in vaginal cytology and changes in appearance and volume of cervical mucus) provides an indirect estimate of the estrogenic effect upon the target organs and, therefore, it should only be used adjunctively with more direct estimates of follicular development (ultrasonography and serum estradiol determinations).",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;text-align:justify;\">",
"     The clinical confirmation of ovulation is obtained by direct and indirect indices of progesterone production. The indices most generally used are: rise in basal body temperature, increase in serum progesterone, and menstruation following the shift in basal body temperature.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;text-align:justify;\">",
"     Monitor for signs and symptoms of OHSS for at least 2 weeks following hCG administration.",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F248401\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Bravelle (AT, DE, ES, GB, GR, HK, IE, IL, NO, SE);",
"     </li>",
"     <li>",
"      Foligem (IN);",
"     </li>",
"     <li>",
"      Follegon (TW);",
"     </li>",
"     <li>",
"      Follimon (KP, TH);",
"     </li>",
"     <li>",
"      Follitrin (AR, CN, PY, UY);",
"     </li>",
"     <li>",
"      Fostimon (AT, BE, BG, CH, CZ, DK, FI, FR, GB, HN, IL, IT, MX, NL, PL, PT);",
"     </li>",
"     <li>",
"      Fostipur (ES);",
"     </li>",
"     <li>",
"      Lishenbao (CL);",
"     </li>",
"     <li>",
"      Metrodin (HK, MY);",
"     </li>",
"     <li>",
"      Metrodin HP (BR, NZ)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F248383\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Urofollitropin is a preparation of highly purified follicle-stimulating hormone (FSH) extracted from the urine of postmenopausal women. Follitropins stimulate ovarian follicular growth in women who do not have primary ovarian failure. FSH is required for normal follicular growth, maturation, gonadal steroid production, and spermatogenesis.",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F248399\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Half-life elimination",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     I.M.: 37 hours, 15 hours following multiple doses",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     SubQ: 32 hours, 21 hours following multiple doses",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Time to peak, plasma:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     I.M.: 17 hours, 11 hours following multiple doses",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     SubQ: 21 hours, 10 hours following multiple doses",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Dickey RP, Thornton M, Nichols J, et al, &ldquo;Comparison of the Efficacy and Safety of a Highly Purified Human Follicle-Stimulating Hormone (Bravelle) and Recombinant Follitropin-Beta for",
"      <i>",
"       in vitro",
"      </i>",
"      Fertilization: A Prospective, Randomized Study,&rdquo;",
"      <i>",
"       Fertil Steril",
"      </i>",
"      , 2002, 77(6):1202-8.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?31/60/32708/abstract-text/12057729/pubmed\" id=\"12057729\" target=\"_blank\">",
"        12057729",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Mohamed MA, Sbracia M, Pacchiarotti A, et al, &ldquo;Urinary Follicle-Stimulating Hormone (FSH) Is More Effective Than Recombinant FSH in Older Women in a Controlled Randomized Study,&rdquo;",
"      <i>",
"       Fertil Steril",
"      </i>",
"      , 2006, 85(5):1398-403.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?31/60/32708/abstract-text/16600226/pubmed\" id=\"16600226\" target=\"_blank\">",
"        16600226",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 9490 Version 33.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1105-122.72.76.133-906C751B57-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_60_32708=[""].join("\n");
var outline_f31_60_32708=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3878204\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F248402\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5032785\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3878217\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F248395\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F248397\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F248396\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3878210\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F248400\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F248385\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13300197\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6223598\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F248391\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3878205\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3878207\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16324119\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3878220\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F248401\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F248383\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F248399\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9490\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9490|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?28/1/28692?source=related_link\">",
"      Urofollitropin (purified human follicle stimulating hormone): Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f31_60_32709="Temozolomide: Patient drug information";
var content_f31_60_32709=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Temozolomide: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?10/47/11000?source=see_link\">",
"     see \"Temozolomide: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?30/37/31319?source=see_link\">",
"     see \"Temozolomide: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F225270\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Temodar&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F225271\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Ahi-Temozolomide Capsules;",
"     </li>",
"     <li>",
"      Temodal&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10022276\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10022278\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691761",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat brain cancer.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691672",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat cancer.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10022277\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702995",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to temozolomide, dacarbazine, or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701080",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are pregnant or may be pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701047",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are breast-feeding.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10022282\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697282",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have kidney disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697290",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have liver disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698463",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your blood work checked often. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697613",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with your doctor before getting any vaccines. Use with this drug may either raise the chance of an infection or make the vaccine not work as well.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697622",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with your doctor before using products that have aspirin, blood thinners, garlic, ginseng, ginkgo, ibuprofen or like products, pain drugs, or vitamin E.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697740",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use birth control that you can trust to stop pregnancy while taking this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697025",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are a man and have sex, protect your partner from pregnancy. Use 2 kinds of birth control that you can trust.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10022283\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698315",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You may have more chance of getting an infection. Wash hands often. Stay away from people with infections, colds, or flu.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698119",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698275",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help. You may need drugs to lower this side effect. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697978",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Hard stools (constipation). Drinking more liquids, working out, or adding fiber to your diet may help. Talk with your doctor about a stool softener or laxative.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697998",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Loose stools (diarrhea).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698360",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Swelling in the arms or legs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698114",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Hair loss. Hair most often grows back when this drug is stopped.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698074",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling tired or weak.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698984",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Not hungry.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698220",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Low white blood cell count or low platelet count.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698189",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Irritation where the shot is given.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10022285\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699105",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any bruising or bleeding.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10022280\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705490",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Oral:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696185",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use as you have been told, even if you are feeling better.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695852",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take this drug at the same time of day.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695860",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take at bedtime to stop upset stomach.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695912",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take with or without food. Always take with food or always take on an empty stomach.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695899",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take with a full glass of water.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695700",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Swallow capsule whole. Do not chew, break, or crush.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694655",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       How this drug is taken may change based on blood work results, side effects, and how well the drug is working.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694364",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       There is a liquid if you cannot swallow pills. Shake well before use.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696260",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Wear gloves when touching this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695191",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you throw up after taking this drug, do not repeat the dose.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705429",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Shot:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695989",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is given as a shot into a vein over a period of time.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10022281\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705490",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Oral:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10022286\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705490",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Oral:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699364",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store capsules at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699478",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store liquid (suspension) in a refrigerator. Throw away any part not used after 2 months.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10022287\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11074 Version 34.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1003-122.72.76.133-24348CF07F-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_60_32709=[""].join("\n");
var outline_f31_60_32709=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F225270\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F225271\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022276\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022278\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022277\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022282\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022283\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022285\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022280\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022281\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022286\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022287\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?10/47/11000?source=related_link\">",
"      Temozolomide: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?30/37/31319?source=related_link\">",
"      Temozolomide: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f31_60_32710="Lines of Blaschko";
var content_f31_60_32710=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F57219&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F57219&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 489px\">",
"   <div class=\"ttl\">",
"    Lines of Blaschko",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 469px; height: 576px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The pattern assumed by many different naevoid and acquired skin diseases on the human skin and mucosae. The cause of the pattern of Blaschko lines is unknown; they do not follow nerves, vessels, or lymphatics. The lines described by these conditions not only did not correspond to any known anatomical basis, but were remarkably consistent both from patient to patient and even from one disease to another. The lines may represent a clinical expression of a genetically programmed clone of altered cells, perhaps first expressed during embryogenesis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Med Art (www.med-ars.it). Copyright &copy; 2010.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_60_32710=[""].join("\n");
var outline_f31_60_32710=null;
var title_f31_60_32711="Gross images of breast angiosarcoma";
var content_f31_60_32711=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F86979&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F86979&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Gross images of breast angiosarcoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 399px; height: 597px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A) Mastectomy specimen from a patient with a radiation-associated angiosarcoma. Note the diffuse purple-blue discoloration of the skin and multiple raised red-black nodules on the skin.",
"    <br>",
"     B)&nbsp;A close up image of the nodules which appear to be blood-filled, scabbed, and within an indurated patch.",
"     <div class=\"footnotes\">",
"     </div>",
"     <div class=\"reference\">",
"      Courtesy of Drs. Alero Inyang and David Lucas.",
"     </div>",
"    </br>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_60_32711=[""].join("\n");
var outline_f31_60_32711=null;
var title_f31_60_32712="Erythema multiforme genital";
var content_f31_60_32712=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F75314%7EDERM%2F58969&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F75314%7EDERM%2F58969&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Erythema multiforme",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Erosions are present on the penis of this patient with erythema multiforme. A target-like lesion is present on the distal glans.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Erythema multiforme",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 324px; height: 432px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Hemorrhagic crusting and mucosal erosions involving the lips and tongue in a patient with erythema multiforme.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_60_32712=[""].join("\n");
var outline_f31_60_32712=null;
var title_f31_60_32713="Nephrology pattern 7";
var content_f31_60_32713=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F79428&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F79428&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1133px;\">",
"  <div class=\"figure\" style=\"width: 563px\">",
"   <div class=\"ttl\">",
"    Nephrology pattern 7",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 543px; height: 249px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
"  <div class=\"figure\" style=\"width: 450px\">",
"   <div class=\"ttl\">",
"    Electron micrograph of a normal glomerulus",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 377px; height: 266px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Electron micrograph of a normal glomerular capillary loop showing the fenestrated endothelial cell (Endo), the glomerular basement membrane (GBM), and the epithelial cells with its interdigitating foot processes (arrow). The GBM is thin, and no electron dense deposits are present. Two normal platelets are seen in the capillary lumen.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Helmut Rennke, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_60_32713=[""].join("\n");
var outline_f31_60_32713=null;
var title_f31_60_32714="Urticarial vasculitis";
var content_f31_60_32714=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"6\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Urticarial vasculitis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?31/60/32714/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?31/60/32714/contributors\">",
"     Jerry D Brewer, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?31/60/32714/contributors\">",
"     Mark DP Davis, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?31/60/32714/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?31/60/32714/contributors\">",
"     John H Stone, MD, MPH",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?31/60/32714/contributors\">",
"     Jeffrey Callen, MD, FACP, FAAD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?31/60/32714/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?31/60/32714/contributors\">",
"     Paul L Romain, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?31/60/32714/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 11, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Urticarial vasculitis (UV) is considered a clinicopathologic entity consisting of two elements:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Clinical manifestations of urticaria",
"     </li>",
"     <li>",
"      Histopathological evidence of cutaneous leukocytoclastic vasculitis (LCV) of the small vessels, largely involving the postcapillary venules [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/1-4\">",
"       1-4",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Although UV is most commonly idiopathic, it can occur in association with autoimmune diseases, drug reactions, infections, or malignancy. UV may be systemic or localized to the skin [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/5\">",
"     5",
"    </a>",
"    ]. Hypocomplementemia, when present, may be associated with extensive vasculitis and systemic features that most commonly involve the musculoskeletal, pulmonary, renal,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    gastrointestinal systems. Discussion of this topic is confounded by the lack of accepted criteria for distinguishing UV from other cutaneous vasculitides and associated conditions.",
"   </p>",
"   <p>",
"    A detailed literature review of this subject has been published by the authors [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/6\">",
"     6",
"    </a>",
"    ]. The epidemiology, clinical features, laboratory and biopsy findings, differential diagnosis, treatment and prognosis of UV are reviewed here. A more general discussion of urticaria and related conditions is presented elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/19/30010?source=see_link\">",
"     \"Chronic urticaria: Clinical manifestations, diagnosis, pathogenesis, and natural history\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     TERMINOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;UV is characterized by a variety of cutaneous, systemic, and serologic features, which have resulted in a confusing array of names for this disorder(s).",
"   </p>",
"   <p>",
"    UV likely represents a continuum of disease, ranging from urticaria with minimal vasculitis, to life- or organ-threatening systemic vasculitis with minimal urticaria. Some patients have low complement levels, a feature that is associated with more severe disease and with systemic involvement. By comparison, patients with normal complement levels are more likely to have mild disease (sometimes referred to as normocomplementemic urticarial vasculitis [NUV]).",
"   </p>",
"   <p>",
"    Based upon complement levels and presence",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    absence of specific systemic findings, some of the terms that appear in the literature include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Hypocomplementemic urticarial vasculitis syndrome (HUVS) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/7\">",
"       7",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Hypocomplementemic urticarial vasculitis (HUV) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/8\">",
"       8",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Unusual systemic lupus erythematosus (SLE)-like syndrome [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/9\">",
"       9",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Urticaria and arthralgia with necrotizing angiitis [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/10\">",
"       10",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Hypocomplementemia with cutaneous vasculitis and arthritis [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/1\">",
"       1",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    HUV and HUVS are the terms that appear most prominently in the literature. The distinctions between these two syndromes are discussed below.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Hypocomplementemic urticarial vasculitis syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hypocomplementemic urticarial vasculitis syndrome (HUVS) has been recognized as a specific autoimmune disorder involving six or more months of urticaria with hypocomplementemia, in the presence of various systemic findings [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/1,7,9,11-16\">",
"     1,7,9,11-16",
"    </a>",
"    ]. HUVS can occur independently or can be associated with other conditions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/5\">",
"     5",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H27\">",
"     'Associated conditions'",
"    </a>",
"    below.) Diagnostic criteria for HUVS have been proposed (",
"    <a class=\"graphic graphic_table graphicRef82138 \" href=\"mobipreview.htm?18/10/18603\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Systemic features include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Arthritis or arthralgias",
"     </li>",
"     <li>",
"      Mild glomerulonephritis",
"     </li>",
"     <li>",
"      Uveitis or episcleritis",
"     </li>",
"     <li>",
"      Recurrent abdominal pain",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These criteria, unaltered since their original proposal, are not specific enough to define any individual disorder. Venulitis of the dermis (established via biopsy) with a characteristic immunofluorescence staining is essential to the diagnosis. (See",
"    <a class=\"local\" href=\"#H12\">",
"     'Immunofluorescence'",
"    </a>",
"    below.) When measured, C1q levels are frequently found to be low, although the specificity and positive predictive value of this finding are not clear and patients with systemic lupus erythematosus may also have decreased C1q levels [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/13\">",
"     13",
"    </a>",
"    ]. Thus, whether a depressed C1q level is necessary to diagnose HUVS is unresolved. Anti-C1q antibodies (C1q precipitins) are present in most patients with HUVS, although this test is not widely available [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/17\">",
"     17",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H10\">",
"     'Pathophysiology'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Hypocomplementemic urticarial vasculitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hypocomplementemic urticarial vasculitis (HUV) is the term used to describe patients with UV and hypocomplementemia who do not meet diagnostic criteria for HUVS. In general, patients with HUV have cutaneous disease and few or no systemic manifestations.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     SYNDROMES",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are several other recognized syndromes, less common than HUVS, which can be observed with UV. These include AHA syndrome, Schnitzler's syndrome, Cogan's syndrome, and Muckle-Wells syndrome. Each of these syndromes is rarely associated with UV.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     AHA syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;The AHA syndrome consists of UV with arthritis (A), hives (H), and angioedema (A). Flares may be associated with emotional stress, anxiety, exercise, and excessive alcohol consumption [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Schnitzler's syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Schnitzler&rsquo;s syndrome is a form of chronic urticaria associated with monoclonal gammopathy (most often IgM kappa) and additional features, which may include bone pain, skeletal hyperostosis, arthralgias, lymphadenopathy, and intermittent fevers [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/19-25\">",
"     19-25",
"    </a>",
"    ]. Hematologic malignancy is reported in between 15 and 45 percent of patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/19,25\">",
"     19,25",
"    </a>",
"    ]. Initial reports of this syndrome described urticarial vasculitis as a feature of this syndrome, but subsequent studies demonstrated that a neutrophilic urticarial dermatosis is most common. Indeed, a retrospective analysis of 20 patients seen at the Mayo Clinic did not identify LCV in any of the patients studied [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/25\">",
"     25",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This condition generally responds very well to inhibition of the interleukin (IL)-1 pathway. The role of IL-1 signaling in disease pathogenesis is highlighted by treatment response to",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?0/18/294?source=see_link\">",
"     anakinra",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/24,26-28\">",
"     24,26-28",
"    </a>",
"    ] (an IL-1 receptor antagonist),",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?16/21/16724?source=see_link\">",
"     rilonacept",
"    </a>",
"    (an IL-1 binding and neutralizing fusion protein), and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?40/52/41796?source=see_link\">",
"     canakinumab",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/29\">",
"     29",
"    </a>",
"    ] (a monoclonal antibody against IL-1&beta;).",
"   </p>",
"   <p>",
"    Three patients unresponsive to IL-1 inhibition have been described who responded to IL-6 pathway inhibition with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?43/19/44342?source=see_link\">",
"     tocilizumab",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/30\">",
"     30",
"    </a>",
"    ], the anti-IL-6 receptor antibody, suggesting the possibility of an alternative disease mechanism in some patients. Symptomatic improvement occurs in some patients with treatment using pefloxacin [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/31\">",
"     31",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Cogan's syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cogan&rsquo;s syndrome is a rare inflammatory disorder characterized by interstitial keratitis and vestibuloauditory dysfunction, which has been infrequently seen in patients with UV. This is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/42/12968?source=see_link\">",
"     \"Cogan&rsquo;s syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Muckle-Wells syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Muckle-Wells syndrome is an autosomal dominant systemic inflammatory disorder associated with the development of UV, deafness, and renal amyloidosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/32\">",
"     32",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?23/58/24487?source=see_link&amp;anchor=H6#H6\">",
"     \"Cryopyrin-associated periodic syndromes and related disorders\", section on 'Muckle-Wells syndrome'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     PATHOPHYSIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;UV is believed to result from the formation of immune complexes in the blood that then deposit in vessel walls. In support of this hypothesis are the findings on skin biopsy (see below), the association of UV with some disorders in which the antigen-antibody complexes are well defined (eg, hepatitis B, hepatitis C), and the observation that removal of immune complexes by plasmapheresis is temporally associated with the resolution of the urticarial lesions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/33-35\">",
"     33-35",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The antigens eliciting the formation of antibodies are not known in many cases of UV. Medications and viruses (particularly hepatitis B and C) have been implicated as the target antigen in some cases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/36,37\">",
"     36,37",
"    </a>",
"    ]. There have also been reports demonstrating the development of UV in association with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?28/6/28776?source=see_link\">",
"     infliximab",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?16/3/16437?source=see_link\">",
"     glatiramer acetate",
"    </a>",
"    , and the injection of hyaluronic acid dermal filler agents [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/38-40\">",
"     38-40",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In some patients with UV (particularly those with HUVS), a collagen-like region on C1q has been implicated as the antigenic target [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/5,33\">",
"     5,33",
"    </a>",
"    ]. The autoantibody is referred to as a C1q precipitin. A causative role of these specific autoantibodies in the pathogenesis of UV has not been established [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/7,17,35,41-43\">",
"     7,17,35,41-43",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Once antigen-antibody complexes have formed, they can activate the classical complement pathway. This generates C3a and C5a, which cause mast cell degranulation resulting in urticarial eruptions. C3a and C5a also cause increased vessel permeability and chemotaxis of neutrophils. Infiltrating neutrophils release proteolytic enzymes, causing further tissue destruction and edema [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/34\">",
"     34",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     HISTOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Histologic findings in leukocytoclastic vasculitis (LCV), which are observed in UV as well as other disorders, include the following [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/2,4,36,44-46\">",
"     2,4,36,44-46",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Injury and swelling of endothelial cells, usually of the postcapillary venules",
"     </li>",
"     <li>",
"      Extravasation of red blood cells",
"     </li>",
"     <li>",
"      Fragmentation of leukocytes with nuclear debris (leukocytoclasis)",
"     </li>",
"     <li>",
"      Fibrin deposition in and around the vessels",
"     </li>",
"     <li>",
"      Perivascular infiltrate composed mostly of neutrophils",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Leukocytoclasis and fibrinoid deposits are probably the most important aspects of LCV as they represent direct signs of vessel damage.",
"   </p>",
"   <p>",
"    A continuum exists in the amount and type of blood vessel inflammation seen histologically in UV, ranging from a sparse perivascular infiltrate with no leukocytoclasis to a dense infiltrate with frank leukocytoclasis and fibrin deposition in the most severe forms [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/35,44,47\">",
"     35,44,47",
"    </a>",
"    ]. These more severe findings, typically with a neutrophilic infiltrate, are seen in patients with HUVS. Rarely, lymphocytic, as opposed to leukocytoclastic, vasculitis may be observed [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/48\">",
"     48",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Immunofluorescence",
"    </span>",
"    &nbsp;&mdash;&nbsp;Immunofluorescence reveals deposits of immunoglobulins, complement, or fibrin around blood vessels in most patients with UV [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/33,49\">",
"     33,49",
"    </a>",
"    ]. Deposits are located in the basement membrane zone of the dermal-epidermal junction (",
"    <a class=\"graphic graphic_picture graphicRef65429 \" href=\"mobipreview.htm?22/4/22594\">",
"     picture 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_picture graphicRef78194 \" href=\"mobipreview.htm?6/22/6498\">",
"     picture 2",
"    </a>",
"    ). Active urticarial lesions stain positive for immunoglobulin and complement deposits approximately 80 percent of the time [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/50\">",
"     50",
"    </a>",
"    ]. The findings can also be seen in non-lesional skin.",
"   </p>",
"   <p>",
"    These findings are not specific to UV and are also frequently seen in patients with SLE [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/44\">",
"     44",
"    </a>",
"    ]. Thus, the finding of immunoglobulin and complement deposits within the basement membrane zone should prompt consideration of both diagnoses [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/47\">",
"     47",
"    </a>",
"    ]. Seventy percent of UV patients with deposits at the dermal-epidermal junction have renal involvement [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/49\">",
"     49",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;UV is a rare disorder, although the incidence and prevalence are uncertain. This is partly due to a lack of clarity in the medical literature resulting from the variety of cutaneous, systemic, and serologic features associated with the disease. As an example, the prevalence of UV in patients with chronic urticaria varies from 5 to 20 percent, depending on the definition of vasculitis used [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/3,33,44,51-55\">",
"     3,33,44,51-55",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Women comprise 60 to 80 percent of reported patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/33,50,56\">",
"     33,50,56",
"    </a>",
"    ]. The peak reported incidence is in the fourth decade of life [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/47,50\">",
"     47,50",
"    </a>",
"    ]. UV has also been described in children; the youngest reported case occurred in a patient one year of age [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/57\">",
"     57",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     CLINICAL PRESENTATION",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Dermatologic findings",
"    </span>",
"    &nbsp;&mdash;&nbsp;The urticarial lesions (or wheals) of UV can be found anywhere on the body (",
"    <a class=\"graphic graphic_picture graphicRef66203 graphicRef54877 \" href=\"mobipreview.htm?15/5/15447\">",
"     picture 3A-B",
"    </a>",
"    and",
"    <a class=\"graphic graphic_picture graphicRef77924 \" href=\"mobipreview.htm?38/53/39760\">",
"     picture 4",
"    </a>",
"    and",
"    <a class=\"graphic graphic_picture graphicRef66672 \" href=\"mobipreview.htm?8/57/9108\">",
"     picture 5",
"    </a>",
"    and",
"    <a class=\"graphic graphic_picture graphicRef81159 \" href=\"mobipreview.htm?28/47/29424\">",
"     picture 6",
"    </a>",
"    ). Several of the following features can help distinguish UV wheals from those in common urticaria (",
"    <a class=\"graphic graphic_table graphicRef77125 \" href=\"mobipreview.htm?7/47/7931\">",
"     table 2",
"    </a>",
"    ), although none is diagnostic:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Common urticaria is pruritic and not painful. By comparison, up to one-third of patients with UV report burning and tenderness as well as pruritus [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/50\">",
"       50",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Individual lesions in UV last longer than those in chronic urticaria, persisting for more than 24 hours in two-thirds of patients, and sometimes for up to 72 hours. Resolution of these wheals may be associated with purpura and hyperpigmentation in up to 35 percent.",
"     </li>",
"     <li>",
"      When examined with a diascope (a magnifying lens or glass slide applied to the skin over several drops of contact solution), wheals can have a central dark red or brown macule, signifying underlying purpura and vasculitis (",
"      <a class=\"graphic graphic_picture graphicRef60497 \" href=\"mobipreview.htm?39/21/40273\">",
"       picture 7",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/58\">",
"       58",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      UV can present as angioedema when the vasculitis involves the capillary or postcapillary venules of the deeper layers of the dermis and submucosa [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/36\">",
"       36",
"      </a>",
"      ]. Swelling resembling angioedema has been reported in approximately 40 percent of UV patients in some series, and residual bruising is typical [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/50\">",
"       50",
"      </a>",
"      ]. Edema can develop in areas of focused pressure, causing confusion in differentiating UV from delayed pressure urticaria. In such cases, skin biopsy would demonstrate the distinguishing finding of LCV in UV [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/33\">",
"       33",
"      </a>",
"      ]. Patients with UV can also develop laryngeal edema, although this is uncommon [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/7\">",
"       7",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Other associated cutaneous disorders include livedo reticularis, erythema multiforme-like eruptions, and rarely bullous eruptions (",
"      <a class=\"graphic graphic_table graphicRef82169 \" href=\"mobipreview.htm?1/52/1868\">",
"       table 3",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/11,36,59,60\">",
"       11,36,59,60",
"      </a>",
"      ]. Raynaud phenomenon may occur [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/61\">",
"       61",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Systemic symptoms",
"    </span>",
"    &nbsp;&mdash;&nbsp;The many systemic manifestations associated with UV (",
"    <a class=\"graphic graphic_table graphicRef82169 \" href=\"mobipreview.htm?1/52/1868\">",
"     table 3",
"    </a>",
"    ) are presented in the following section, categorized by organ system.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Musculoskeletal",
"    </span>",
"    &nbsp;&mdash;&nbsp;Arthralgias and arthritis are the most common systemic manifestation of UV, with roughly 50 percent of patients reporting arthralgias, usually accompanying cutaneous disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/49,50\">",
"     49,50",
"    </a>",
"    ]. Joint pain is usually migratory and transient, frequently affecting the hands, elbows, feet, ankles, and knees. Frank arthritis is seen in up to 50 percent of cases of HUVS.",
"   </p>",
"   <p>",
"    Jaccoud's arthropathy is seen in HUVS, although it is more often associated with SLE [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/62-66\">",
"     62-66",
"    </a>",
"    ]. It is characterized by the typical deformities of rheumatoid arthritis (ulnar deviation, swan neck deformities, and subluxations) in the absence of radiographic evidence of joint destruction (unlike true rheumatoid arthritis) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/67\">",
"     67",
"    </a>",
"    ]. It may be associated with an increased risk of aortic and mitral valvulopathy, warranting echocardiographic evaluation in these patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/68,69\">",
"     68,69",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The involvement of muscle is not well documented and may be largely subclinical. There are reports of muscle biopsies showing myositis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Renal",
"    </span>",
"    &nbsp;&mdash;&nbsp;Renal disease is characterized by proteinuria and hematuria, with a number of different disease entities described histologically. The renal disease of UV may not be distinguishable from that of other entities. These include proliferative glomerulonephritis, focal necrotizing vasculitis, crescentic glomerulonephritis, membranoproliferative glomerulonephritis, and tubulointerstitial nephritis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/49,70-72\">",
"     49,70-72",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Mild non-progressive renal disease is typical of UV, although there have been occasional reports of end-stage renal disease requiring hemodialysis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/33,73\">",
"     33,73",
"    </a>",
"    ]. In contrast, HUVS patients typically have moderate-to-heavy proteinuria and mild renal failure.",
"   </p>",
"   <p>",
"    The renal involvement of UV tends to be more severe in children [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/74\">",
"     74",
"    </a>",
"    ]. Although UV is rare in the pediatric population, it should be considered when a combination of urticaria, glomerulonephritis, arthritis or arthralgias, and pulmonary disease co-exist [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/70\">",
"     70",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h3\">",
"     Pulmonary",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pulmonary involvement, a leading cause of morbidity and mortality in UV, may include cough, dyspnea, hemoptysis, chronic obstructive pulmonary disease (COPD), asthma, pleuritis, and pleural effusions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/14,50,75-78\">",
"     14,50,75-78",
"    </a>",
"    ]. Tracheal stenosis has also been reported [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The most common pulmonary manifestations are COPD and asthma, seen in up to 20 percent of patients with HUVS and in 5 percent of patients with normocomplementemic UV [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/47,50\">",
"     47,50",
"    </a>",
"    ]. Most patients with COPD and UV are also smokers, although the amount of lung disease present is typically far greater than would be expected for the level of tobacco exposure, and there have even been reports of patients with COPD and UV who never smoked [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/13,50,79,80\">",
"     13,50,79,80",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Pulmonary destruction is postulated to occur from vasculitis within the lung tissue, leading to neutrophilic release of elastase and the development of emphysematous lung disease. Smoking is thought to accelerate this process by helping to recruit neutrophils [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/13\">",
"     13",
"    </a>",
"    ]. Thus, patients with UV or HUVS should not smoke and should avoid second-hand smoke.",
"   </p>",
"   <p>",
"    An interesting speculation is that anti-C1q antibodies may cross-react with pulmonary surfactant apoproteins, which also contain a C1q collagen-like binding region. This cross reactivity could be a contributing factor to the pulmonary disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/81\">",
"     81",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h3\">",
"     Gastrointestinal",
"    </span>",
"    &nbsp;&mdash;&nbsp;Gastrointestinal symptoms, seen in up to one third of patients, include substernal pain, abdominal pain, nausea, vomiting, and diarrhea. Hepatomegaly and splenomegaly have been reported. Gastrointestinal bleeding is not associated with UV [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/44,49,59\">",
"     44,49,59",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h3\">",
"     Other systems",
"    </span>",
"    &nbsp;&mdash;&nbsp;Involvement of other organ systems is less frequently observed.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Ophthalmologic &mdash; Ophthalmologic involvement is seen in only 10 percent of UV patients [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/36\">",
"       36",
"      </a>",
"      ]. Eye findings can include episcleritis, uveitis, and conjunctivitis [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/49,50,82,83\">",
"       49,50,82,83",
"      </a>",
"      ]. A rare case of serpiginous choroidopathy with subsequent blindness was reported, as has optic atrophy. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?0/5/80?source=see_link\">",
"       \"Episcleritis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Cardiovascular &mdash; Cardiac disease is rare in UV. Findings have included pericarditis, tamponade, valvular disease, and pericardial effusion [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/76,81,84\">",
"       76,81,84",
"      </a>",
"      ]. Valvular disease has been seen in patients with HUVS and Jaccoud's arthropathy.",
"     </li>",
"     <li>",
"      Neurologic &mdash; Central nervous system involvement includes pseudotumor cerebri (the most common CNS manifestation), aseptic meningitis, cranial nerve palsies, peripheral neuropathy, and transverse myelitis [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/76,85-89\">",
"       76,85-89",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h1\">",
"     LABORATORY FINDINGS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most common abnormal laboratory results associated with UV include [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/34,90\">",
"     34,90",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Elevated erythrocyte sedimentation rate (ESR)",
"     </li>",
"     <li>",
"      Hypocomplementemia (usually decreased C1q, C3, and C4)",
"     </li>",
"     <li>",
"      Circulating immune complexes",
"     </li>",
"     <li>",
"      Positive ANA",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Erythrocyte sedimentation rate",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although commonly elevated, the ESR is not related to the severity of the disease or to the extent of systemic involvement [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/34,91\">",
"     34,91",
"    </a>",
"    ]. An elevated ESR can also be found in patients with typical urticaria without evidence of vasculitis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/44\">",
"     44",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Hypocomplementemia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hypocomplementemia is a sensitive marker for systemic disease and correlates with severity of illness [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/47,50,56,71,92\">",
"     47,50,56,71,92",
"    </a>",
"    ]. In patients with UV, decreased C1, C1q, C2, C3,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    C4 levels, as well as a reduction in the",
"    <span class=\"nowrap\">",
"     CH50/100,",
"    </span>",
"    due to activation of the classical complement pathway, may be found. C1q, C3, and C4 are probably the most commonly reduced components. A depressed C1q level is found in most patients with hypocomplementemic urticarial vasculitis syndrome [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/1,5,34,47\">",
"     1,5,34,47",
"    </a>",
"    ], as discussed above. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?10/25/10647?source=see_link\">",
"     \"Overview and clinical assessment of the complement system\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     Antinuclear antibodies",
"    </span>",
"    &nbsp;&mdash;&nbsp;A large percentage of patients with UV are ANA positive, some in high titers. Although UV patients are anti-dsDNA antibody negative as a rule, distinguishing some patients with UV from those with SLE may be challenging. Many patients with UV meet criteria set forth by the American College of Rheumatology (ACR) for the diagnosis of SLE [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/34,93\">",
"     34,93",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H27\">",
"     'Associated conditions'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     Other laboratory tests",
"    </span>",
"    &nbsp;&mdash;&nbsp;Other laboratory findings may include positive hepatitis B or C serologies, elevated Epstein-Barr virus titers, or positive serologies for Borrelia species. Abnormal laboratory values suggesting specific organ involvement (particularly renal disease) may be observed. (See",
"    <a class=\"local\" href=\"#H40\">",
"     'Laboratory studies'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h1\">",
"     ASSOCIATED CONDITIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although most cases are idiopathic, there are a variety of conditions associated with UV (",
"    <a class=\"graphic graphic_table graphicRef82455 \" href=\"mobipreview.htm?9/46/9964\">",
"     table 4",
"    </a>",
"    ). Their causal role has not been established. Connective tissue diseases are the most commonly associated conditions, particularly SLE and Sj&ouml;gren's syndrome [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/94-99\">",
"     94-99",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h2\">",
"     Lupus",
"    </span>",
"    &nbsp;&mdash;&nbsp;UV and SLE share many clinical features, including the following [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/34,100\">",
"     34,100",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Fifty percent of patients with UV and hypocomplementemia meet the classification criteria for a diagnosis of SLE [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/47\">",
"       47",
"      </a>",
"      ]. In contrast, only 2 percent of those with normocomplementemic UV meet the SLE criteria.",
"     </li>",
"     <li>",
"      Some patients with UV have a lupus-like syndrome, multi-organ involvement, and positive ANA. However, as mentioned previously, these UV patients lack anti-dsDNA and fail to meet ACR criteria for SLE [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/34,93\">",
"       34,93",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Urticaria is a fairly common finding in patients with SLE [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/94,95,101,102\">",
"       94,95,101,102",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Autoantibodies against C1q can be found in both HUVS and SLE. They are seen rarely in a variety of other autoimmune conditions. (See",
"      <a class=\"local\" href=\"#H42\">",
"       'Differential diagnosis'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      UV can be a presenting feature, or more commonly, can develop in patients with longstanding SLE [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/103\">",
"       103",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    However, some conditions seen in association with HUVS are unusual among those with SLE. Patients with HUVS can have angioedema (up to 50 percent), COPD (up to 50 percent), and ocular manifestations, especially of the uveal tract (30 percent).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h2\">",
"     Sj&ouml;gren's syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Skin lesions in Sj&ouml;gren&rsquo;s syndrome are more purpuric than urticarial, and tend to be located on the lower extremities [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/104\">",
"     104",
"    </a>",
"    ]. Patients with Sj&ouml;gren&rsquo;s syndrome and UV commonly demonstrate the anti-Ro (SSA) antibody.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h2\">",
"     Medication use",
"    </span>",
"    &nbsp;&mdash;&nbsp;Medications from virtually every drug class have been associated with the development of UV [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/105\">",
"     105",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/57/30614?source=see_link\">",
"     \"Hypersensitivity vasculitis in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31\">",
"    <span class=\"h2\">",
"     Infections",
"    </span>",
"    &nbsp;&mdash;&nbsp;Infections may be associated with the development of UV. These include hepatitis B [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/37\">",
"     37",
"    </a>",
"    ], hepatitis C [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/106\">",
"     106",
"    </a>",
"    ], Lyme disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/107\">",
"     107",
"    </a>",
"    ], and infectious mononucleosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/108\">",
"     108",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H32\">",
"    <span class=\"h2\">",
"     Serum sickness",
"    </span>",
"    &nbsp;&mdash;&nbsp;Serum sickness is a disease in which non-human proteins form immune complexes that cause vasculitis and urticarial eruptions. Biopsies of these urticarial lesions sometimes show signs of dermal venulitis and inflammation leading to the diagnosis of UV [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/61,109\">",
"     61,109",
"    </a>",
"    ]. However, the term serum sickness is generally applied to a self-limited condition occurring in temporal association with an identifiable exogenous trigger. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?8/40/8842?source=see_link\">",
"     \"Serum sickness and serum sickness-like reactions\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H33\">",
"    <span class=\"h2\">",
"     Complement disorders",
"    </span>",
"    &nbsp;&mdash;&nbsp;Inherited complement deficiencies of C3 or C4, and secondary C3 deficiency due to the presence of C3 nephritic factor have been associated with UV [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/110-113\">",
"     110-113",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/58/42920?source=see_link\">",
"     \"Inherited disorders of the complement system\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H34\">",
"    <span class=\"h2\">",
"     Malignancy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Malignancy has also been implicated in UV, albeit rarely. Specifically, Hodgkin lymphoma, IgA myeloma, metastatic adenocarcinoma of the colon, metastatic malignant testicular teratoma, acute nonlymphocytic leukemia, acute myeloid leukemia, agnogenic myelodysplasia, and B-cell non-Hodgkin lymphoma have been noted in association with UV [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/114-120\">",
"     114-120",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H35\">",
"    <span class=\"h2\">",
"     Miscellaneous",
"    </span>",
"    &nbsp;&mdash;&nbsp;A variety of other miscellaneous conditions have been seen in association with UV. These include monoclonal IgG gammopathy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/121\">",
"     121",
"    </a>",
"    ], idiopathic thrombocytopenia purpura [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/50\">",
"     50",
"    </a>",
"    ], polycythemia vera [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/122\">",
"     122",
"    </a>",
"    ], cryoglobulinemia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/123\">",
"     123",
"    </a>",
"    ], inflammatory bowel disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/50\">",
"     50",
"    </a>",
"    ], striae distensae of pregnancy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/124\">",
"     124",
"    </a>",
"    ], and rarely cold [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/125-127\">",
"     125-127",
"    </a>",
"    ] and solar or heat induced urticaria [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/34,128\">",
"     34,128",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H36\">",
"    <span class=\"h1\">",
"     DIAGNOSTIC APPROACH",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of UV should be considered in the presence of persistent or recurrent urticaria with suggestive clinical characteristics, serologic findings, or evidence of systemic disease.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H37\">",
"    <span class=\"h2\">",
"     History",
"    </span>",
"    &nbsp;&mdash;&nbsp;The history should address the following:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Symptoms of systemic disease",
"     </li>",
"     <li>",
"      Preceding infections",
"     </li>",
"     <li>",
"      Preceding drug ingestion",
"     </li>",
"     <li>",
"      Prior associated conditions (see",
"      <a class=\"local\" href=\"#H27\">",
"       'Associated conditions'",
"      </a>",
"      above)",
"     </li>",
"     <li>",
"      Behavior and characteristics of the urticarial lesions (",
"      <a class=\"graphic graphic_table graphicRef77125 \" href=\"mobipreview.htm?7/47/7931\">",
"       table 2",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Response of the skin lesions to treatment",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H38\">",
"    <span class=\"h2\">",
"     Physical examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;Physical examination is directed at determining the physical characteristics of the urticarial lesions and detecting signs of systemic disease. (See",
"    <a class=\"local\" href=\"#H15\">",
"     'Dermatologic findings'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H16\">",
"     'Systemic symptoms'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H39\">",
"    <span class=\"h2\">",
"     Skin biopsy",
"    </span>",
"    &nbsp;&mdash;&nbsp;If UV is suspected, skin biopsy of one or more early lesions is obtained in order to establish the presence of LCV. By definition, the diagnosis of UV requires the presence of both characteristic clinical manifestations and pathologic evidence of LCV; thus, a biopsy should always be performed to establish the diagnosis of UV, even if the clinical presentation appears typical of UV or HUVS. Tissue without fixation for direct immunofluorescence, as well as formalin-fixed tissue for hematoxylin and eosin staining, is sent to the laboratory [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/33\">",
"     33",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H11\">",
"     'Histology'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    In our clinic, we initially obtain two punch biopsies of early lesions and cut one of the samples into two halves. We place one-half of one sample promptly into liquid nitrogen for direct immunofluorescence, and send the remaining tissue in formalin for hematoxylin and eosin staining. Formalin interferes with the performance of immunofluorescence.",
"   </p>",
"   <p>",
"    If the results do not demonstrate LCV and clinical suspicion for UV remains high, we suggest repeat biopsy on a newly developed lesion. Multiple biopsies are sometimes needed to establish the diagnosis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H40\">",
"    <span class=\"h2\">",
"     Laboratory studies",
"    </span>",
"    &nbsp;&mdash;&nbsp;If LCV is confirmed, then an evaluation for hypocomplementemia and the presence of systemic disease is required. The following tests should be performed in patients who meet both the clinical and pathologic criteria for UV and HUVS:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Complement studies (CH50, C3, C4 and C1q levels)",
"     </li>",
"     <li>",
"      Complete blood count with differential",
"     </li>",
"     <li>",
"      Urinalysis",
"     </li>",
"     <li>",
"      Serum creatinine and blood urea nitrogen",
"     </li>",
"     <li>",
"      ESR",
"     </li>",
"     <li>",
"      Hepatitis B surface antigen",
"     </li>",
"     <li>",
"      Hepatitis C serologies",
"     </li>",
"     <li>",
"      ANA",
"     </li>",
"     <li>",
"      Anti-double stranded-DNA",
"     </li>",
"     <li>",
"      Anti-Ro, -La, -Sm, and -RNP antibodies",
"     </li>",
"     <li>",
"      Anti-neutrophil cytoplasmic antibodies (ANCA), particularly enzyme immunoassays for antibodies to proteinase-3 and myeloperoxidase (PR3- and MPO-ANCA)",
"     </li>",
"     <li>",
"      Rheumatoid factor",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      anti-cyclic citrullinated peptides (anti-CCP)",
"     </li>",
"     <li>",
"      Immunofixation electrophoresis",
"     </li>",
"     <li>",
"      Cryoglobulins and cryofibrinogens",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In addition, C1q precipitin (anti C1q antibody) assays have become available in a number of laboratories. When available, these assays should also be obtained as a decreased C1q level due to anti C1q antibodies would be characteristic of HUVS.",
"   </p>",
"   <p>",
"    Other investigations should be guided by findings from the history and physical examination [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/61\">",
"     61",
"    </a>",
"    ]. As an example, chest imaging and pulmonary function tests are appropriate in patients with pulmonary symptoms. Skeletal x-rays are useful to evaluate patients with arthralgias and arthritis-type pain.",
"   </p>",
"   <p>",
"    Malignancy is rarely associated with UV, and screening patients for underlying malignancy, beyond the age-appropriate recommendations, is not reasonable unless a thorough history and physical exam leads to a strong suspicion of occult cancer [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/123\">",
"     123",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H41\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of UV is confirmed by the presence of both:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Clinical manifestations of urticaria",
"     </li>",
"     <li>",
"      Histopathological evidence of LCV",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The presence or absence of hypocomplementemia",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    associated conditions can help determine whether UV can be further delineated into HUVS, HUV, or NUV",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    whether UV is associated with another pathogenic process. (See",
"    <a class=\"local\" href=\"#H2\">",
"     'Terminology'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H27\">",
"     'Associated conditions'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H42\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Other diseases to consider in the diagnosis of UV include acute urticaria, chronic urticaria, and chronic neutrophilic vasculitis manifesting as palpable purpura. Patients with urticarial vasculitis can occasionally present with lesions that mimic erythema multiforme. Among these diseases, there are several clinical and histopathological characteristics that are used for differentiation.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Common urticaria &mdash; Certain clinical features can help distinguish UV wheals from those in common urticaria, although these are not diagnostic (",
"      <a class=\"graphic graphic_table graphicRef77125 \" href=\"mobipreview.htm?7/47/7931\">",
"       table 2",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Dermatologic findings'",
"      </a>",
"      above.) Histopathologically, acute urticaria has marked dermal edema in the absence of endothelial cell swelling, leukocytoclasis, or red blood cell extravasation. A sparse leukocytic perivascular infiltrate may occasionally be seen [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/4,36\">",
"       4,36",
"      </a>",
"      ]. Complement levels are normal.",
"      <br/>",
"      <br/>",
"      Chronic urticaria may have perivascular infiltrates composed of T cells, macrophages, and eosinophils. In contrast to UV, leukocytoclasis and fibrinoid degeneration are always absent, red cell extravasation is rarely seen, and immunofluorescence staining of immunoglobulins and complement is negative [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/99,129\">",
"       99,129",
"      </a>",
"      ]. Complement levels are normal. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?29/19/30010?source=see_link\">",
"       \"Chronic urticaria: Clinical manifestations, diagnosis, pathogenesis, and natural history\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Erythema multiforme (EM) minor &mdash; EM minor is an acute eruption characterized by distinctive target or iris lesions with a predilection for the extensor surfaces of the extremities, as well as the palms and soles. EM minor can be preceded by infections (typically Herpes virus or Mycoplasma) and has a benign clinical course. Histology of EM minor shows a perivascular mononuclear infiltrate. Complement levels are normal. Although the appearance of the lesions of EM minor can be similar to that of UV, the two can usually be distinguished by the larger clinical picture and the pathology. In contrast, EM major is a more severe blistering disease involving the mucous membranes that would not be confused with UV.",
"     </li>",
"     <li>",
"      Acquired angioedema &mdash; Angioedema in an adult patient with a depressed C1q level should also prompt consideration of acquired C1-inhibitor deficiency, a condition that is associated with B cell lymphomas in a substantial percentage of patients [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/130\">",
"       130",
"      </a>",
"      ]. Like HUVS, there are a number of reports suggesting an association between acquired",
"      <span class=\"nowrap\">",
"       angioedema/acquired",
"      </span>",
"      C1-inhibitor deficiency and SLE and lupus-like conditions [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/131-137\">",
"       131-137",
"      </a>",
"      ]. A difference between HUVS and acquired C1-inhibitor deficiency is that urticaria is not seen in the latter. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?25/20/25927?source=see_link\">",
"       \"Acquired C1 inhibitor deficiency: Management and prognosis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Neutrophilic urticarial dermatosis &mdash; Neutrophilic urticarial dermatosis is characterized by an urticarial eruption with the histopathologic features of a perivascular and interstitial neutrophilic infiltrate with intense leukocytoclasia without vasculitis or edema. In addition the urticarial lesions in this condition generally resolve within 24 hours. Purpura, angioedema, and facial swelling have not been associated with neutrophilic urticarial dermatosis, however in a recent report of nine patients, seven had associated systemic diseases including adult-onset Still&rsquo;s disease, SLE, and Schnitzler syndrome [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/138\">",
"       138",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H43\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The treatment of UV is often challenging and therapy is not standardized. Agents are chosen based upon the severity of the disease and presence of systemic involvement (",
"    <a class=\"graphic graphic_table graphicRef55294 \" href=\"mobipreview.htm?1/56/1932\">",
"     table 5",
"    </a>",
"    ). The approach outlined here is based upon case and series reports of successful therapies. Randomized and controlled trials have not been performed.",
"   </p>",
"   <p>",
"    The assistance of a rheumatologist with experience in the management of vasculitides is recommended for patients who have evidence of significant systemic disease.",
"   </p>",
"   <p>",
"    Antihistamines are used as first-line therapy in all patients with",
"    <span class=\"nowrap\">",
"     UV/HUVS",
"    </span>",
"    and any degree of cutaneous disease. If first-line therapy does not control symptoms or if systemic disease is present, additional medications are employed.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H44\">",
"    <span class=\"h2\">",
"     Cutaneous disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most patients with cutaneous disease require antihistamines for symptomatic relief of itching. Additional agents are usually necessary for improvement and control of the lesions. Additional therapies are needed to clear the skin lesions and prevent additional lesions from appearing. Glucocorticoids,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/59/32688?source=see_link\">",
"     dapsone",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?2/26/2471?source=see_link\">",
"     hydroxychloroquine",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/13/32983?source=see_link\">",
"     colchicine",
"    </a>",
"    are the most commonly used agents, although there is more experience with glucocorticoids and dapsone than the other medications.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Antihistamines &mdash; Antihistamines are administered in cutaneous UV to manage pruritus. These drugs do not impact the course of the disease and one preparation has not been shown to be superior to another for this condition [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/35,36,49,71\">",
"       35,36,49,71",
"      </a>",
"      ]. We start with a non-sedating agent, such as",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?7/39/7799?source=see_link\">",
"       loratadine",
"      </a>",
"      (10 mg once daily),",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?34/33/35350?source=see_link\">",
"       fexofenadine",
"      </a>",
"      (60 mg once or twice daily), or",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?35/34/36390?source=see_link\">",
"       cetirizine",
"      </a>",
"      (10 mg once daily).",
"      <br/>",
"      <br/>",
"      If the patient is still having unmanageable pruritus, the sedating antihistamines are added, in addition to the less-sedating agents above.",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?33/2/33824?source=see_link\">",
"       Diphenhydramine",
"      </a>",
"      and",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?23/52/24390?source=see_link\">",
"       chlorpheniramine",
"      </a>",
"      are over-the-counter options. Prescription agents include",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?31/51/32560?source=see_link\">",
"       doxepin",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?0/24/391?source=see_link\">",
"       hydroxyzine",
"      </a>",
"      , or",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?15/20/15688?source=see_link\">",
"       promethazine",
"      </a>",
"      &nbsp;(see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?0/7/117?source=see_link\">",
"       \"Chronic urticaria: Standard management and patient education\"",
"      </a>",
"      ).",
"      <br/>",
"      <br/>",
"      The patient should be informed about side effects (drowsiness, head ache, dry mouth, constipation, dizziness, and confusion), and drug-drug interactions should be checked in regards to the other medications the patient is concurrently taking.",
"     </li>",
"     <li>",
"      Glucocorticoids &mdash; Systemic glucocorticoids are considered the mainstay of therapy for UV. Most patients with hypocomplementemia require this therapy to achieve control of the illness [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/44,50\">",
"       44,50",
"      </a>",
"      ]. We use this therapy to gain control of the disease in patients with significant illness or systemic involvement.",
"      <br/>",
"      <br/>",
"      Dosing of glucocorticoids varies and is usually dictated by the severity of systemic illness. We begin treatment at doses between 0.5 and 1.0",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      per day. Benefits from glucocorticoids are usually noticeable within a day or two of initiation. We would recommend giving these medications for at least a week before making an assessment about clinical response. Rarely, a patient may require glucocorticoid doses of 1.5",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      per day, however these cases are unusual, and we recommend staying between 0.5 and 1.0",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      per day for most patients.",
"      <br/>",
"      <br/>",
"      Some patients can be tapered off glucocorticoid therapy over time, although many cannot and require protracted use [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/139\">",
"       139",
"      </a>",
"      ]. In such cases, the lowest possible dose sufficient to control the vasculitis should be employed. The use of alternate day therapy has not been reported for UV. Because of the long-term sequelae of glucocorticoids, other therapeutic options should be considered in such patients and efforts made to find adjunctive treatments that might allow for lowering of the chronic glucocorticoid dose.",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?31/59/32688?source=see_link\">",
"       Dapsone",
"      </a>",
"      &mdash; Dapsone, a sulfone used successfully in the therapy of UV and HUVS, is relatively inexpensive, usually well tolerated (with certain important exceptions noted below), and simple to administer [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/56,80,91,139-143\">",
"       56,80,91,139-143",
"      </a>",
"      ]. For these reasons, it is favored by some authors in the treatment of UV and HUVS. Based on limited numbers of case reports, we suggest the use of dapsone, in preference to glucocorticoids, in patients with HUVS and pulmonary involvement, because dapsone has reportedly arrested lung damage when used early in the course of the disease [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/80\">",
"       80",
"      </a>",
"      ]. We start with a dose of 50 mg once daily and increase to 100 mg once daily if needed.",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?13/28/13765?source=see_link\">",
"       Pentoxifylline",
"      </a>",
"      acts synergistically with dapsone and can be added as adjunctive therapy, although we generally use dapsone as a single agent initially [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/144\">",
"       144",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      Because dapsone is a sulfone, patients with glucose-6-phosphate dehydrogenase (G6PD) deficiency may experience severe hemolysis when exposed to this drug, and G6PD levels should be checked prior to initiating therapy with this agent [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/36\">",
"       36",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      Other side effects of therapy with dapsone include headaches, nonhemolytic anemia, and agranulocytosis, requiring intermittent CBCs for monitoring. Although rare, dapsone hypersensitivity syndrome is a potentially fatal complication [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/145\">",
"       145",
"      </a>",
"      ] characterized by fever, hemolytic anemia, lymphocytosis, and transaminitis. Finally, methemoglobinemia can occur with dapsone [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/146\">",
"       146",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?2/26/2471?source=see_link\">",
"       Hydroxychloroquine",
"      </a>",
"      &mdash; Hydroxychloroquine, an antimalarial, has been beneficial therapy for patients with UV and limited skin involvement [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/71,147\">",
"       71,147",
"      </a>",
"      ]. It is given at a dose of 200 mg orally BID for people &gt;70 kg and 200 mg once daily for people &lt;70 kg. There have been case reports in the literature showing complete clearing of cutaneous disease and normalization of renal function when hydroxychloroquine is used with low-dose",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?37/43/38585?source=see_link\">",
"       prednisone",
"      </a>",
"      [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/148\">",
"       148",
"      </a>",
"      ]. Monitoring of patients receiving hydroxychloroquine is discussed separately. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?42/9/43161?source=see_link\">",
"       \"Antimalarial drugs in the treatment of rheumatic disease\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?32/13/32983?source=see_link\">",
"       Colchicine",
"      </a>",
"      &mdash; Colchicine, an alkaloid, has been used effectively to treat UV. It is a teratogen and should be used with caution [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/34,139,149-152\">",
"       34,139,149-152",
"      </a>",
"      ]. CBCs should be ordered after initiation of treatment to screen for cytopenias associated with this drug [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/36\">",
"       36",
"      </a>",
"      ]. Colchicine works by slowing neutrophil chemotaxis and stabilizing lysosomal membranes [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/153\">",
"       153",
"      </a>",
"      ]. We use colchicine for UV at starting doses of 0.5 to 0.6 mg orally per day. This drug may also be administered twice daily (ie, 0.25 to 0.3 mg twice daily). If minimal to no response is noted after a few weeks, the dose of colchicine may be increased to 1.5 mg per day (or 0.75 mg twice daily).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H45\">",
"    <span class=\"h2\">",
"     Systemic disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;For systemic disease, commonly used therapies include NSAIDs for arthralgias and arthritis specifically, and glucocorticoids or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/59/32688?source=see_link\">",
"     dapsone",
"    </a>",
"    for other systemic symptoms (",
"    <a class=\"graphic graphic_table graphicRef55294 \" href=\"mobipreview.htm?1/56/1932\">",
"     table 5",
"    </a>",
"    ). Interferon alfa has been used for UV associated with hepatitis. The administration of glucocorticoids and dapsone is discussed above. (See",
"    <a class=\"local\" href=\"#H44\">",
"     'Cutaneous disease'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Nonsteroidal anti-inflammatory drugs &mdash; NSAIDs are commonly used to treat the arthralgias and arthritis of UV, with good results in up to 50 percent of patients [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/50,56\">",
"       50,56",
"      </a>",
"      ]. We begin with",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?15/38/15978?source=see_link\">",
"       ibuprofen",
"      </a>",
"      up to 800 three or four times daily or",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?42/43/43705?source=see_link\">",
"       naproxen",
"      </a>",
"      500 mg BID.",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?35/50/36649?source=see_link\">",
"       Indomethacin",
"      </a>",
"      , 25 mg three times daily, increasing as needed to a maximum dose of 50 mg four times daily is another option, although this medication can cause gastrointestinal irritation and headaches.",
"     </li>",
"     <li>",
"      Interferon alfa &mdash; Interferon alfa has been used in UV associated with hepatitis C or A infection, either alone or in combination with",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?26/25/27033?source=see_link\">",
"       ribavirin",
"      </a>",
"      [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/5,116,154-156\">",
"       5,116,154-156",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H46\">",
"    <span class=\"h2\">",
"     Severe or refractory systemic disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;For severe or refractory systemic disease, other agents can be helpful and are often used in combination with glucocorticoids. These include",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?38/3/38967?source=see_link\">",
"     azathioprine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?9/20/9546?source=see_link\">",
"     cyclophosphamide",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?4/29/4569?source=see_link\">",
"     mycophenolate",
"    </a>",
"    mofetil, cyclosporin,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/38/24170?source=see_link\">",
"     methotrexate",
"    </a>",
"    , and plasma exchange. Combinations of drugs have been used successfully to treat specific systemic manifestations of UV (",
"    <a class=\"graphic graphic_table graphicRef55294 \" href=\"mobipreview.htm?1/56/1932\">",
"     table 5",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?38/3/38967?source=see_link\">",
"       Azathioprine",
"      </a>",
"      &mdash; Azathioprine has been associated with beneficial results in the setting of UV [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/36,61,157\">",
"       36,61,157",
"      </a>",
"      ]. When azathioprine is used with",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?24/40/25223?source=see_link\">",
"       allopurinol",
"      </a>",
"      , the dose of azathioprine must be reduced at least five-fold. When used in combination with",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?37/43/38585?source=see_link\">",
"       prednisone",
"      </a>",
"      , azathioprine is associated with marked beneficial improvement in renal disease [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/13,44,125,158\">",
"       13,44,125,158",
"      </a>",
"      ] and cutaneous involvement of HUVS [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/159\">",
"       159",
"      </a>",
"      ]. Testing for deficiency of one or both alleles for thiopurine methyltransferase (TPMT), the enzyme required to metabolize azathioprine, is strongly advised before the institution of this treatment [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/160\">",
"       160",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      If the TPMT level is within normal range, the starting dose is 1",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      daily. This may be increased by 0.5",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      daily if no effect is apparent after a few weeks. If TPMT levels are low, lower doses of azathioprine are used; if the TPMT level is high, higher doses can be used. If TPMT testing is not available, the starting dose should not be greater than 50",
"      <span class=\"nowrap\">",
"       mg/day,",
"      </span>",
"      with an increase as tolerated after two to three weeks. The maximum recommended dose is 2.5",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      daily.",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?9/20/9546?source=see_link\">",
"       Cyclophosphamide",
"      </a>",
"      &mdash; Cyclophosphamide can be given orally or intravenously. When used with pulse",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?33/4/33856?source=see_link\">",
"       dexamethasone",
"      </a>",
"      therapy, cyclophosphamide has been beneficial in refractory cases of HUVS [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/161\">",
"       161",
"      </a>",
"      ]. The starting dose is 60",
"      <span class=\"nowrap\">",
"       mg/m2",
"      </span>",
"      daily, which can be increased to 120",
"      <span class=\"nowrap\">",
"       mg/m2",
"      </span>",
"      if needed.",
"      <br/>",
"      <br/>",
"      Cyclophosphamide is associated with the development of leukemia, as well as hemorrhagic cystitis, cytopenias, and sterility [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/36\">",
"       36",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      Dosing must be adjusted for decreased renal function and hyperbilirubinemia, and cyclophosphamide should not be administered to patients with bilirubin levels in excess of 5",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/162\">",
"       162",
"      </a>",
"      ]. There is a case report of moderate success with \"triple therapy\" using systemic glucocorticoids,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?31/59/32688?source=see_link\">",
"       dapsone",
"      </a>",
"      , and cyclophosphamide [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/145\">",
"       145",
"      </a>",
"      ]. This should be reserved for resistant cases in which single agent therapies have failed.",
"     </li>",
"     <li>",
"      Cyclosporin A &mdash; Cyclosporin A (CyA) has been used effectively in HUVS, particularly for renal and pulmonary disease [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/5,163,164\">",
"       5,163,164",
"      </a>",
"      ]. CyA has also been a useful agent to use when attempting to taper glucocorticoid therapy [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/74\">",
"       74",
"      </a>",
"      ]. Initial dosing is 2 to 2.5",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      daily. If no response is noted after a few weeks, this dosing can be increased to 5",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      daily. It is also important to remember that CyA should not be used in patients with hypertension",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      renal disease.",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?4/29/4569?source=see_link\">",
"       Mycophenolate",
"      </a>",
"      mofetil &mdash; Mycophenolate mofetil was reported as effective maintenance therapy in one case of HUVS after symptoms were controlled with glucocorticoids and",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?9/20/9546?source=see_link\">",
"       cyclophosphamide",
"      </a>",
"      [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/165\">",
"       165",
"      </a>",
"      ]. Doses of 30 to 45",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      daily are suggested.",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?23/38/24170?source=see_link\">",
"       Methotrexate",
"      </a>",
"      &mdash; Methotrexate can be used in UV although not as an adjuvant therapy to glucocorticoids [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/166\">",
"       166",
"      </a>",
"      ]. The effects of this drug are often not very pronounced, and methotrexate has even been implicated in the exacerbation of UV [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/167\">",
"       167",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Plasma exchange therapy &mdash; Plasma exchange therapy was used successfully to treat a relapse of HUVS that occurred in a patient who had previously undergone renal transplantation [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/168\">",
"       168",
"      </a>",
"      ]. Disease relapse after the completion of therapy has been reported [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/35,56\">",
"       35,56",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?40/12/41161?source=see_link\">",
"       Rituximab",
"      </a>",
"      &ndash; Rituximab has been used in several patients with recalcitrant UV with a variable degree of success [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/169,170\">",
"       169,170",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?0/18/294?source=see_link\">",
"       Anakinra",
"      </a>",
"      &mdash; Anakinra has been used in patients with Schnitzler&rsquo;s syndrome unresponsive to other therapies [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/26,27\">",
"       26,27",
"      </a>",
"      ]. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Schnitzler's syndrome'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H47\">",
"    <span class=\"h2\">",
"     Other therapies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Other therapies reported in the literature include intravenous immunoglobulin,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?16/35/16950?source=see_link\">",
"     reserpine",
"    </a>",
"    , anti-B-cell therapy, and monoclonal antibody therapy; however, these are limited to single case reports and further evaluation is needed before they can be recommended [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/33,36,152,169,171-173\">",
"     33,36,152,169,171-173",
"    </a>",
"    ]. Therapies that most likely offer little benefit and are not recommended include calcium channel blockers,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?13/28/13765?source=see_link\">",
"     pentoxifylline",
"    </a>",
"    as a single agent, and dietary manipulations [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/5,174\">",
"     5,174",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H48\">",
"    <span class=\"h1\">",
"     PROGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UV is a complicated disease with an unpredictable outcome. It is usually benign, with no permanent sequelae, in the majority of patients with normal complement levels. The average duration of disease is three to four years, although individual cases extending beyond 20 years have been reported [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/49,50\">",
"     49,50",
"    </a>",
"    ]. In the largest series studied, patients with UV had no other disease manifestations over a 12-year span [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/59\">",
"     59",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Patients with hypocomplementemia have more severe disease and may experience significant morbidity and mortality [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/33\">",
"     33",
"    </a>",
"    ]; however, they rarely die as a direct result of the disease, even in the setting of multisystem involvement [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/49\">",
"     49",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Patients with HUVS suffer the greatest morbidity and mortality, largely related to complications of COPD [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/59\">",
"     59",
"    </a>",
"    ] . There have been rare reports of fatal episodes of laryngeal edema [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/60/32714/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H49\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H50\">",
"    <span class=\"h2\">",
"     Presentation and diagnosis",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Urticarial vasculitis is a clinicopathologic entity consisting of urticaria and evidence of leukocytoclastic vasculitis on skin biopsy. UV can be a localized dermatologic condition or a systemic disorder. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Hypocomplementemic urticarial vasculitis syndrome (HUVS) is recognized as a specific autoimmune disorder involving six or more months of urticaria, with hypocomplementemia, in the presence of various systemic findings (",
"      <a class=\"graphic graphic_table graphicRef82138 \" href=\"mobipreview.htm?18/10/18603\">",
"       table 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Terminology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The pathophysiology of UV is believed to involve the deposition of immune complexes in vessel walls, complement activation, and mast cell degranulation due to C3a and C5a with resultant urticaria. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Pathophysiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Leukocytoclasis, or fragmentation of leukocytes with nuclear debris, and fibrinoid deposits are important histopathologic findings that represent direct signs of vessel damage. Immunofluorescence reveals deposits of immunoglobulins, complement, or fibrin around blood vessels in most patients. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Histology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The urticarial lesions of UV can be found anywhere on the body (",
"      <a class=\"graphic graphic_picture graphicRef66203 graphicRef54877 \" href=\"mobipreview.htm?15/5/15447\">",
"       picture 3A-B",
"      </a>",
"      and",
"      <a class=\"graphic graphic_picture graphicRef77924 \" href=\"mobipreview.htm?38/53/39760\">",
"       picture 4",
"      </a>",
"      and",
"      <a class=\"graphic graphic_picture graphicRef66672 \" href=\"mobipreview.htm?8/57/9108\">",
"       picture 5",
"      </a>",
"      and",
"      <a class=\"graphic graphic_picture graphicRef81159 \" href=\"mobipreview.htm?28/47/29424\">",
"       picture 6",
"      </a>",
"      ). Certain features can help distinguish UV wheals from those in common urticaria (",
"      <a class=\"graphic graphic_table graphicRef77125 \" href=\"mobipreview.htm?7/47/7931\">",
"       table 2",
"      </a>",
"      ), although none is diagnostic. Systemic findings most often involve the musculoskeletal, renal, and pulmonary systems. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Clinical presentation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      UV is most commonly idiopathic, although it can occur in association with autoimmune diseases, drug reactions, infections, or malignancy (",
"      <a class=\"graphic graphic_table graphicRef82455 \" href=\"mobipreview.htm?9/46/9964\">",
"       table 4",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H27\">",
"       'Associated conditions'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The diagnosis of UV requires the presence of urticaria with leukocytoclastic vasculitis (LCV) on skin biopsy. If LCV is present, then further testing is indicated to define the presence and extent of systemic disease and evaluate for associated conditions. (See",
"      <a class=\"local\" href=\"#H41\">",
"       'Diagnosis'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H39\">",
"       'Skin biopsy'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H22\">",
"       'Laboratory findings'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H42\">",
"       'Differential diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      UV is a benign and self-limited disease for the majority of patients, although symptoms can last for decades in some individuals. (See",
"      <a class=\"local\" href=\"#H48\">",
"       'Prognosis'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H51\">",
"    <span class=\"h2\">",
"     Treatment recommendations",
"    </span>",
"    &nbsp;&mdash;&nbsp;UV is often difficult to treat and therapy is based upon case reports and small series. Agents are chosen based upon the severity of the disease and presence of systemic involvement (",
"    <a class=\"graphic graphic_table graphicRef55294 \" href=\"mobipreview.htm?1/56/1932\">",
"     table 5",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The management of cutaneous disease includes control of pruritus and prevention of further urticarial lesions. For pruritus, we recommend nonsedating antihistamines initially, followed by the addition of first generation sedating antihistamines, if needed (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). A variety of agents can be used. (See",
"      <a class=\"local\" href=\"#H44\">",
"       'Cutaneous disease'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      To prevent continued development of cutaneous lesions, we suggest glucocorticoids as an initial treatment for most patients (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). We suggest an initial dose of between 0.5 and 1.0",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      of",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?37/43/38585?source=see_link\">",
"       prednisone",
"      </a>",
"      or equivalent per day. (See",
"      <a class=\"local\" href=\"#H44\">",
"       'Cutaneous disease'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The treatment of systemic symptoms depends upon the severity of disease (",
"      <a class=\"graphic graphic_table graphicRef55294 \" href=\"mobipreview.htm?1/56/1932\">",
"       table 5",
"      </a>",
"      ). NSAIDS are recommended for arthralgias and arthritis (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). For most other systemic symptoms, we suggest glucocorticoids, which are used in this setting for the dual purpose of cutaneous and systemic disease control (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). In patients with HUVS and pulmonary involvement, we suggest",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?31/59/32688?source=see_link\">",
"       dapsone",
"      </a>",
"      in preference to glucocorticoids (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H45\">",
"       'Systemic disease'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Experience with the treatment of severe or refractory systemic disease is too limited to make specific recommendations. However, reports of successful therapy using combinations of immunosuppressive medications are reviewed above. (See",
"      <a class=\"local\" href=\"#H46\">",
"       'Severe or refractory systemic disease'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/1\">",
"      McDuffie FC, Sams WM Jr, Maldonado JE, et al. Hypocomplementemia with cutaneous vasculitis and arthritis. Possible immune complex syndrome. Mayo Clin Proc 1973; 48:340.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/2\">",
"      Soter NA. Chronic urticaria as a manifestation of necrotizing venulitis. N Engl J Med 1977; 296:1440.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/3\">",
"      Warin RP. Urticarial vasculitis. Br Med J (Clin Res Ed) 1983; 286:1919.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/4\">",
"      Huston DP, Bressler RB. Urticaria and angioedema. Med Clin North Am 1992; 76:805.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/5\">",
"      Wisnieski JJ. Urticarial vasculitis. Curr Opin Rheumatol 2000; 12:24.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/6\">",
"      Davis MD, Brewer JD. Urticarial vasculitis and hypocomplementemic urticarial vasculitis syndrome. Immunol Allergy Clin North Am 2004; 24:183.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/7\">",
"      Zeiss CR, Burch FX, Marder RJ, et al. A hypocomplementemic vasculitic urticarial syndrome. Report of four new cases and definition of the disease. Am J Med 1980; 68:867.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/8\">",
"      Chen HJ, Bloch KJ. Hypocomplementemic urticarial vasculitis, jaccoud's arthropathy, valvular heart disease, and reversible tracheal stenosis: a surfeit of syndromes. J Rheumatol 2001; 28:383.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/9\">",
"      Agnello V, Ruddy S, Winchester RJ, et al. Hereditary C2 deficiency in systemic lupus erythematosus and acquired complement abnormalities in an unusual SLE-related syndrome. Birth Defects Orig Artic Ser 1975; 11:312.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/10\">",
"      Soter NA, Austen KF, Gigli I. Urticaria and arthralgias as manifestations of necrotizing angiitis (vasculitis). J Invest Dermatol 1974; 63:485.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/11\">",
"      Oishi M, Takano M, Miyachi K, et al. A case of unusual SLE related syndrome characterized by erythema multiforme, angioneurotic edema, marked hypocomplementemia, and Clq precipitins of the low molecular weight type. Int Arch Allergy Appl Immunol 1976; 50:463.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/12\">",
"      Agnello V, Koffler D, Eisenberg JW, et al. C1g precipitins in the sera of patients with systemic lupus erythematosus and other hypocomplementemic states: characterization of high and low molecular weight types. J Exp Med 1971; 134:228s.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/13\">",
"      Schwartz HR, McDuffie FC, Black LF, et al. Hypocomplementemic urticarial vasculitis: association with chronic obstructive pulmonary disease. Mayo Clin Proc 1982; 57:231.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/14\">",
"      Sissons JG, Peters DK, Williams DG, et al. Skin lesions, angio-oedema, and hypocomplementaemia. Lancet 1974; 2:1350.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/15\">",
"      Feig PU, Soter NA, Yager HM, et al. Vasculitis with urticaria, hypocomplementemia, and multiple system involvement. JAMA 1976; 236:2065.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/16\">",
"      Schultz DR, Perez GO, Volanakis JE, et al. Glomerular disease in two patients with urticaria-cutaneous vasculitis and hypocomplementemia. Am J Kidney Dis 1981; 1:157.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/17\">",
"      Wisnieski JJ, Jones SM. IgG autoantibody to the collagen-like region of Clq in hypocomplementemic urticarial vasculitis syndrome, systemic lupus erythematosus, and 6 other musculoskeletal or rheumatic diseases. J Rheumatol 1992; 19:884.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/18\">",
"      McNeil DJ, Kinsella TD, Crawford AM, Fritzler MJ. The AHA syndrome: arthritis, hives and angioedema. Rheumatol Int 1987; 7:277.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/19\">",
"      de Koning HD, Bodar EJ, van der Meer JW, et al. Schnitzler syndrome: beyond the case reports: review and follow-up of 94 patients with an emphasis on prognosis and treatment. Semin Arthritis Rheum 2007; 37:137.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/20\">",
"      Janier M, Bonvalet D, Blanc MF, et al. Chronic urticaria and macroglobulinemia (Schnitzler's syndrome): report of two cases. J Am Acad Dermatol 1989; 20:206.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/21\">",
"      Schnitzler L, Hurez D, Verret JL. [Chronic urticaria--osteo-condensation--macroglobulinemia. Principal case. Study of 20 cases]. Ann Dermatol Venereol 1989; 116:547.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/22\">",
"      Morita A, Sakakibara S, Yokota M, Tsuji T. A case of urticarial vasculitis associated with macroglobulinemia (Schnitzler's syndrome). J Dermatol 1995; 22:32.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/23\">",
"      Borradori L, Rybojad M, Puissant A, et al. Urticarial vasculitis associated with a monoclonal IgM gammopathy: Schnitzler's syndrome. Br J Dermatol 1990; 123:113.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/24\">",
"      de Koning HD, Bodar EJ, Simon A, et al. Beneficial response to anakinra and thalidomide in Schnitzler's syndrome. Ann Rheum Dis 2006; 65:542.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/25\">",
"      Sokumbi O, Drage LA, Peters MS. Clinical and histopathologic review of Schnitzler syndrome: the Mayo Clinic experience (1972-2011). J Am Acad Dermatol 2012; 67:1289.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/26\">",
"      Dybowski F, Sepp N, Bergerhausen HJ, Braun J. Successful use of anakinra to treat refractory Schnitzler's syndrome. Clin Exp Rheumatol 2008; 26:354.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/27\">",
"      Cascavilla N, Bisceglia M, D'Arena G. Successful treatment of Schnitzler's syndrome with anakinra after failure of rituximab trial. Int J Immunopathol Pharmacol 2010; 23:633.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/28\">",
"      Besada E, Nossent H. Dramatic response to IL1-RA treatment in longstanding multidrug resistant Schnitzler's syndrome: a case report and literature review. Clin Rheumatol 2010; 29:567.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/29\">",
"      de Koning HD, Schalkwijk J, van der Meer JW, Simon A. Successful canakinumab treatment identifies IL-1&beta; as a pivotal mediator in Schnitzler syndrome. J Allergy Clin Immunol 2011; 128:1352.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/30\">",
"      Krause K, Feist E, Fiene M, et al. Complete remission in 3 of 3 anti-IL-6-treated patients with Schnitzler syndrome. J Allergy Clin Immunol 2012; 129:848.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/31\">",
"      Asli B, Bienvenu B, Cordoliani F, et al. Chronic urticaria and monoclonal IgM gammopathy (Schnitzler syndrome): report of 11 cases treated with pefloxacin. Arch Dermatol 2007; 143:1046.",
"     </a>",
"    </li>",
"    <li>",
"     file://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=191900 (Accessed on April 25, 2006).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/33\">",
"      Black AK. Urticarial vasculitis. Clin Dermatol 1999; 17:565.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/34\">",
"      Berg RE, Kantor GR, Bergfeld WF. Urticarial vasculitis. Int J Dermatol 1988; 27:468.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/35\">",
"      Jones RR, Bhogal B, Dash A, Schifferli J. Urticaria and vasculitis: a continuum of histological and immunopathological changes. Br J Dermatol 1983; 108:695.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/36\">",
"      Venzor J, Lee WL, Huston DP. Urticarial vasculitis. Clin Rev Allergy Immunol 2002; 23:201.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/37\">",
"      Dienstag JL, Rhodes AR, Bhan AK, et al. Urticaria associated with acute viral hepatitis type B: studies of pathogenesis. Ann Intern Med 1978; 89:34.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/38\">",
"      Cicek D, Kandi B, Oguz S, et al. An urticarial vasculitis case induced by glatiramer acetate. J Dermatolog Treat 2008; :1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/39\">",
"      Goul&atilde;o J, Cunha H, Anes I, et al. Urticarial vasculitis due do infliximab. J Eur Acad Dermatol Venereol 2008; 22:882.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/40\">",
"      Alijotas-Reig J. Recurrent urticarial vasculitis related to nonanimal hyaluronic acid skin filler injection. Dermatol Surg 2009; 35 Suppl 1:395.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/41\">",
"      Davies KA, Norsworthy PJ, Athanassiou P, Walport MJ. Anti-C1q antibodies activate complement and may be pathogenic in SLE. Arthritis Rheum 1997; 40(suppl):S308.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/42\">",
"      Wisnieski JJ, Naff GB. Serum IgG antibodies to C1q in hypocomplementemic urticarial vasculitis syndrome. Arthritis Rheum 1989; 32:1119.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/43\">",
"      Wisnieski JJ, Jones SM. Comparison of autoantibodies to the collagen-like region of C1q in hypocomplementemic urticarial vasculitis syndrome and systemic lupus erythematosus. J Immunol 1992; 148:1396.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/44\">",
"      Monroe EW. Urticarial vasculitis: an updated review. J Am Acad Dermatol 1981; 5:88.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/45\">",
"      WINKELMANN RK, DITTO WB. CUTANEOUS AND VISCERAL SYNDROMES OF NECROTIZING OR \"ALLERGIC\" ANGIITIS: A STUDY OF 38 CASES. Medicine (Baltimore) 1964; 43:59.",
"     </a>",
"    </li>",
"    <li>",
"     Cox AJ. Pathologic changes in hypersensitivity angiitis. In: The Skin, Helwig EB, Mostofi FK (Eds), The Williams &amp; Wilkins Co, Baltimore 1971. p.279.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/47\">",
"      Davis MD, Daoud MS, Kirby B, et al. Clinicopathologic correlation of hypocomplementemic and normocomplementemic urticarial vasculitis. J Am Acad Dermatol 1998; 38:899.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/48\">",
"      Kao NL, Zeitz HJ. Urticarial skin lesions and polymyositis due to lymphocytic vasculitis. West J Med 1995; 162:156.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/49\">",
"      Sanchez NP, Winkelmann RK, Schroeter AL, Dicken CH. The clinical and histopathologic spectrums of urticarial vasculitis: study of forty cases. J Am Acad Dermatol 1982; 7:599.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/50\">",
"      Mehregan DR, Hall MJ, Gibson LE. Urticarial vasculitis: a histopathologic and clinical review of 72 cases. J Am Acad Dermatol 1992; 26:441.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/51\">",
"      Davis AE 3rd. C1 inhibitor and hereditary angioneurotic edema. Annu Rev Immunol 1988; 6:595.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/52\">",
"      Mathison DA, Arroyave CM, Bhat KN, et al. Hypocomplementemia in chronic idiopathic urticaria. Ann Intern Med 1977; 86:534.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/53\">",
"      Natbony SF, Phillips ME, Elias JM, et al. Histologic studies of chronic idiopathic urticaria. J Allergy Clin Immunol 1983; 71:177.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/54\">",
"      Zuberbier T, Henz BM, Fiebiger E, et al. Anti-FcepsilonRIalpha serum autoantibodies in different subtypes of urticaria. Allergy 2000; 55:951.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/55\">",
"      Champion RH. Urticaria: then and now. Br J Dermatol 1988; 119:427.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/56\">",
"      Aboobaker J, Greaves MW. Urticarial vasculitis. Clin Exp Dermatol 1986; 11:436.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/57\">",
"      Soylu A, Kavuk&ccedil;u S, Uzuner N, et al. Systemic lupus erythematosus presenting with normocomplementemic urticarial vasculitis in a 4-year-old girl. Pediatr Int 2001; 43:420.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/58\">",
"      Dahl MV. Clinical pearl: diascopy helps diagnose urticarial vasculitis. J Am Acad Dermatol 1994; 30:481.",
"     </a>",
"    </li>",
"    <li>",
"     Soter NA. Urticarial vasculitis. In: The Urticarias, Champion RH, Greaves MW, Kobza Black A, Pye RJ (Eds), Churchhill Livingstone, Edinburgh 1985. p.141.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/60\">",
"      Gammon WR, Wheeler CE Jr. Urticarial vasculitis: report of a case and review of the literature. Arch Dermatol 1979; 115:76.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/61\">",
"      O'Donnell B, Black AK. Urticarial vasculitis. Int Angiol 1995; 14:166.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/62\">",
"      Sturgess AS, Littlejohn GO. Jaccoud's arthritis and panvasculitis in the hypocomplementemic urticarial vasculitis syndrome. J Rheumatol 1988; 15:858.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/63\">",
"      Bywaters EGL. Jaccoud's syndrome: a sequel to the joint involvement of systemic lupus erythematosus. Clin Rheum Dis 1975; 1:125.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/64\">",
"      Mizutani W, Quismorio FP Jr. Lupus foot: deforming arthropathy of the feet in systemic lupus erythematosus. J Rheumatol 1984; 11:80.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/65\">",
"      Martini A, Ravelli A, Viola S, Burgio RG. Systemic lupus erythematosus with Jaccoud's arthropathy mimicking juvenile rheumatoid arthritis. Arthritis Rheum 1987; 30:1062.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/66\">",
"      Manthorpe R, Bendixen G, Schi&oslash;ler H, Viderbaek A. Jaccoud's syndrome. A nosographic entity associated with systemic lupus erythematosus. J Rheumatol 1980; 7:169.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/67\">",
"      Ishikawa O, Miyachi Y, Watanabe H. Hypocomplementaemic urticarial vasculitis associated with Jaccoud's syndrome. Br J Dermatol 1997; 137:804.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/68\">",
"      Houser SL, Askenase PW, Palazzo E, Bloch KJ. Valvular heart disease in patients with hypocomplementemic urticarial vasculitis syndrome associated with Jaccoud's arthropathy. Cardiovasc Pathol 2002; 11:210.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/69\">",
"      Palazzo E, Bourgeois P, Meyer O, et al. Hypocomplementemic urticarial vasculitis syndrome, Jaccoud's syndrome, valvulopathy: a new syndromic combination. J Rheumatol 1993; 20:1236.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/70\">",
"      Cadnapaphornchai MA, Saulsbury FT, Norwood VF. Hypocomplementemic urticarial vasculitis: report of a pediatric case. Pediatr Nephrol 2000; 14:328.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/71\">",
"      Callen JP, Kalbfleisch S. Urticarial vasculitis: a report of nine cases and review of the literature. Br J Dermatol 1982; 107:87.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/72\">",
"      Messiaen T, Van Damme B, Kuypers D, et al. Crescentic glomerulonephritis complicating the course of a hypocomplementemic urticarial vasculitis. Clin Nephrol 2000; 54:409.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/73\">",
"      Kobayashi S, Nagase M, Hidaka S, et al. Membranous nephropathy associated with hypocomplementemic urticarial vasculitis: report of two cases and a review of the literature. Nephron 1994; 66:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/74\">",
"      Renard M, Wouters C, Proesmans W. Rapidly progressive glomerulonephritis in a boy with hypocomplementaemic urticarial vasculitis. Eur J Pediatr 1998; 157:243.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/75\">",
"      Falk DK. Pulmonary disease in idiopathic urticarial vasculitis. J Am Acad Dermatol 1984; 11:346.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/76\">",
"      Jones MD, Tsou E, Lack E, Cupps TR. Pulmonary disease in systemic urticarial vasculitis: the role of bronchoalveolar lavage. Am J Med 1990; 88:431.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/77\">",
"      Paira SO. Bilateral pleural effusion in a patient with urticarial vasculitis. Clin Rheumatol 1994; 13:504.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/78\">",
"      Knobler H, Admon D, Leibovici V, Okon E. Urticarial vasculitis and recurrent pleural effusion: a systemic manifestation of urticarial vasculitis. Dermatologica 1986; 172:120.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/79\">",
"      Gibson LE, Su WP. Cutaneous vasculitis. Rheum Dis Clin North Am 1990; 16:309.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/80\">",
"      Eiser AR, Singh P, Shanies HM. Sustained dapsone-induced remission of hypocomplementemic urticarial vasculitis--a case report. Angiology 1997; 48:1019.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/81\">",
"      Babajanians A, Chung-Park M, Wisnieski JJ. Recurrent pericarditis and cardiac tamponade in a patient with hypocomplementemic urticarial vasculitis syndrome. J Rheumatol 1991; 18:752.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/82\">",
"      Corwin JM, Baum J. Iridocyclitis in two patients with hypocomplementemic cutaneous vasculitis. Am J Ophthalmol 1982; 94:111.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/83\">",
"      Bielory L, Noble KG, Frohman LP. Urticarial vasculitis and visual loss. J Allergy Clin Immunol 1991; 88:819.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/84\">",
"      Hong L, Wackers F, Dewar M, et al. Atypical fatal hypocomplementemic urticarial vasculitis with involvement of native and homograft aortic valves in an African American man. J Allergy Clin Immunol 2000; 106:1196.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/85\">",
"      Ludivico CL, Myers AR, Maurer K. Hypocomplementemic urticarial vasculitis with glomerulonephritis and pseudotumor cerebri. Arthritis Rheum 1979; 22:1024.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/86\">",
"      Bonelli U, Guerra L, Bettoli V, Passarini B. Urticarial vasculitis with generalized pustular psoriasis and pseudotumor cerebri: a case report. Ann It Derm Clin Sper 1988; 42:171.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/87\">",
"      Tanaka H, Waga S, Kakizaki Y, et al. Chronic urticaria associated with aseptic meningitis: an atypical urticarial vasculitis? Acta Paediatr Jpn 1997; 39:64.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/88\">",
"      Koul PA, Wahid A, Shah SU, et al. Hypocomplementemic urticarial vasculitis and lower cranial nerve palsies. J Assoc Physicians India 2000; 48:536.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/89\">",
"      Bolla G, Disdier P, Verrot D, et al. Acute transverse myelitis and primary urticarial vasculitis. Clin Rheumatol 1998; 17:250.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/90\">",
"      GOLTZ RW. Cutaneous manifestations of allergic angiitis. J Lancet 1962; 82:218.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/91\">",
"      Wisnieski JJ, Baer AN, Christensen J, et al. Hypocomplementemic urticarial vasculitis syndrome. Clinical and serologic findings in 18 patients. Medicine (Baltimore) 1995; 74:24.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/92\">",
"      RUITER M, HADDERS HN. Predominantly cutaneous forms of necrotising angiitis. J Pathol Bacteriol 1959; 77:71.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/93\">",
"      Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25:1271.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/94\">",
"      O'Loughlin S, Schroeter AL, Jordon RE. Chronic urticaria-like lesions in systemic lupus erythematosus. A review of 12 cases. Arch Dermatol 1978; 114:879.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/95\">",
"      Provost TT, Zone JJ, Synkowski D, et al. Unusual cutaneous manifestations of systemic lupus erythematosus: I. Urticaria-like lesions. Correlation with clinical and serological abnormalities. J Invest Dermatol 1980; 75:495.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/96\">",
"      Ruzicka T, Goerz G. Systemic lupus erythematosus and vasculitic urticaria. Effect of dapsone and complement levels. Dermatologica 1981; 162:203.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/97\">",
"      Van der Horst JC, Bronsveld W. Urticarial vasculitis in a patient with systemic lupus erythematosus: a case report. Clin Exp Dermatol 1981; 6:489.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/98\">",
"      Alexander EL, Arnett FC, Provost TT, Stevens MB. Sj&ouml;gren's syndrome: association of anti-Ro(SS-A) antibodies with vasculitis, hematologic abnormalities, and serologic hyperreactivity. Ann Intern Med 1983; 98:155.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/99\">",
"      Massa MC, Su WP. Lymphocytic vasculitis: is it a specific clinicopathologic entity? J Cutan Pathol 1984; 11:132.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/100\">",
"      Bisaccia E, Adamo V, Rozan SW. Urticarial vasculitis progressing to systemic lupus erythematosus. Arch Dermatol 1988; 124:1088.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/101\">",
"      MCCOMBS RP, PATTERSON JF, MACMAHON HE. Syndromes associated with allergic vasculitis. N Engl J Med 1956; 255:251.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/102\">",
"      Horv&aacute;th A, Kr&aacute;mer M, Ablonczy E. Clinical evaluation and pathomechanism of urticaria-like skin eruption in systemic lupus erythematosus. Acta Derm Venereol 1982; 62:253.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/103\">",
"      Berti S, Moretti S, Lucin C, et al. Urticarial vasculitis and subacute cutaneous lupus erythematosus. Lupus 2005; 14:489.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/104\">",
"      Asherson RA, D'Cruz D, Stephens CJ, et al. Urticarial vasculitis in a connective tissue disease clinic: patterns, presentations, and treatment. Semin Arthritis Rheum 1991; 20:285.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/105\">",
"      Doyle MK, Cuellar ML. Drug-induced vasculitis. Expert Opin Drug Saf 2003; 2:401.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/106\">",
"      Lin RY, Caren CB, Menikoff H. Hypocomplementaemic urticarial vasculitis, interstitial lung disease and hepatitis C. Br J Dermatol 1995; 132:821.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/107\">",
"      Olson JC, Esterly NB. Urticarial vasculitis and Lyme disease. J Am Acad Dermatol 1990; 22:1114.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/108\">",
"      Wands JR, Perrotto JL, Isselbacher KJ. Circulating immune complexes and complement sequence activation in infectious mononucleosis. Am J Med 1976; 60:269.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/109\">",
"      Gammon WR. Manifestations of drug reactions. Urticaria and cutaneous necrotizing venulitis. Clin Dermatol 1986; 4:50.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/110\">",
"      McLean RH, Weinstein A, Chapitis J, et al. Familial partial deficiency of the third component of complement (C3) and the hypocomplementemic cutaneous vasculitis syndrome. Am J Med 1980; 68:549.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/111\">",
"      Glovsky MM, Braunwald J, Opelz G, Alenty A. Hypersensitivity to procarbazine associated with angioedema, urticaria, and low serum complement activity. J Allergy Clin Immunol 1976; 57:134.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/112\">",
"      Borradori L, Rybojad M, Morel P, et al. Chronic urticaria and moderate leukocytoclastic vasculitis associated with C3 nephritic factor activity. Arch Dermatol 1989; 125:1589.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/113\">",
"      Carmichael AJ, Marsden JR. Urticarial vasculitis: a presentation of C3 nephritic factor. Br J Dermatol 1993; 128:589.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/114\">",
"      Strickland DK, Ware RE. Urticarial vasculitis: an autoimmune disorder following therapy for Hodgkin's disease. Med Pediatr Oncol 1995; 25:208.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/115\">",
"      Highet AS. Urticarial vasculitis and IgA myeloma. Br J Dermatol 1980; 102:355.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/116\">",
"      Lipsker D, Cribier B, Maloisel F, et al. Chronic urticaria and IgA myeloma. Acta Derm Venereol 1998; 78:395.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/117\">",
"      Lewis JE. Urticarial vasculitis occurring in association with visceral malignancy. Acta Derm Venereol 1990; 70:345.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/118\">",
"      Sprossmann A, M&uuml;ller RP. [Urticaria-vasculitis syndrome in metastatic malignant testicular teratoma]. Hautarzt 1994; 45:871.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/119\">",
"      Wilson D, McCluggage WG, Wright GD. Urticarial vasculitis: a paraneoplastic presentation of B-cell non-Hodgkin's lymphoma. Rheumatology (Oxford) 2002; 41:476.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/120\">",
"      Garc&iacute;a-Porr&uacute;a C, Gonz&aacute;lez-Gay MA. Cutaneous vasculitis as a paraneoplastic syndrome in adults. Arthritis Rheum 1998; 41:1133.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/121\">",
"      Asherson RA, Buchanan NM, d'Cruz D, Hughes GR. Urticarial vasculitis, IgA deficiency and C1 esterase inhibitor deficiency in the presence of an IgG monoclonal gammopathy--a case report. Clin Exp Dermatol 1992; 17:137.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/122\">",
"      Farell AM, Sabroe RA, Bunker CB. Urticarial vasculitis associated with polycythaemia rubra vera. Clin Exp Dermatol 1996; 21:302.",
"     </a>",
"    </li>",
"    <li>",
"     Matthews KP. Chronic urticaria. In: Clinical management of urticaria and anaphylaxis, Schocket AL (Ed), Marcel Dekker, Inc, New York 1993. p.21.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/124\">",
"      Kwon CW, Lee CW, Kim YT, Kim JH. Urticarial vasculitis developed on the striae distensae during pregnancy. Int J Dermatol 1993; 32:751.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/125\">",
"      Wanderer AA, Nuss DD, Tormey AD, Giclas PC. Urticarial leukocytoclastic vasculitis with cold urticaria. Report of a case and review of the literature. Arch Dermatol 1983; 119:145.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/126\">",
"      Eady RA, Keahey TM, Sibbald RG, Kobza Black A. Cold urticaria with vasculitis: report of a case with light and electron microscopic, immunofluorescence and pharmacological studies. Clin Exp Dermatol 1981; 6:355.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/127\">",
"      Demierre MF, Winkelman WJ. Idiopathic cold-induced urticarial vasculitis and monoclonal IgG gammopathy. Int J Dermatol 1996; 35:151.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/128\">",
"      Armstrong RB, Horan DB, Silvers DN. Leukocytoclastic vasculitis in urticaria induced by ultraviolet irradiation. Arch Dermatol 1985; 121:1145.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/129\">",
"      Boonk WJ, Nieboer C, Huijgens PC. Pathogenetic studies in chronic urticaria. Failure to demonstrate vasculitis, complement activation and fibrinolysis. Dermatologica 1986; 173:264.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/130\">",
"      Cicardi M, Zingale LC, Pappalardo E, et al. Autoantibodies and lymphoproliferative diseases in acquired C1-inhibitor deficiencies. Medicine (Baltimore) 2003; 82:274.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/131\">",
"      Lahiri M, Lim AY. Angioedema and systemic lupus erythematosus--a complementary association? Ann Acad Med Singapore 2007; 36:142.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/132\">",
"      Nettis E, Colanardi MC, Loria MP, Vacca A. Acquired C1-inhibitor deficiency in a patient with systemic lupus erythematosus: a case report and review of the literature. Eur J Clin Invest 2005; 35:781.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/133\">",
"      Aslam A, Misbah SA. Is acquired C1 inhibitor deficiency associated with lupus a distinct disease entity? Comment on the article by Cacoub et al. Arthritis Rheum 2002; 46:2827.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/134\">",
"      Jazwinska EC, Gatenby PA, Dunckley H, Serjeantson SW. C1 inhibitor functional deficiency in systemic lupus erythematosus (SLE). Clin Exp Immunol 1993; 92:268.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/135\">",
"      Ochonisky S, Intrator L, Wechsler J, et al. Acquired C1 inhibitor deficiency revealing systemic lupus erythematosus. Dermatology 1993; 186:261.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/136\">",
"      Wozel G, Rietzschel I. [Acquired deficiency of C1 esterase inhibitor, persistent eyelid edema and subcutaneous lupus erythematosus]. Dermatol Monatsschr 1988; 174:741.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/137\">",
"      Agnello V. Lupus diseases associated with hereditary and acquired deficiencies of complement. Springer Semin Immunopathol 1986; 9:161.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/138\">",
"      Kieffer C, Cribier B, Lipsker D. Neutrophilic urticarial dermatosis: a variant of neutrophilic urticaria strongly associated with systemic disease. Report of 9 new cases and review of the literature. Medicine (Baltimore) 2009; 88:23.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/139\">",
"      Muramatsu C, Tanabe E. Urticarial vasculitis: response to dapsone and colchicine. J Am Acad Dermatol 1985; 13:1055.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/140\">",
"      Matthews CN, Saihan EM, Warin RP. Urticaria-like lesions associated with systemic lupus erythematosus: response to dapsone. Br J Dermatol 1978; 99:455.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/141\">",
"      Fortson JS, Zone JJ, Hammond ME, Groggel GC. Hypocomplementemic urticarial vasculitis syndrome responsive to dapsone. J Am Acad Dermatol 1986; 15:1137.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/142\">",
"      Highet AS. Urticarial vasculitis resembling systemic lupus erythematosus: efficacy of prednisone and dapsone combined. Br J Dermatol 1980; 102:358.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/143\">",
"      Holtman JH, Neustadt DH, Klein J, Callen JP. Dapsone is an effective therapy for the skin lesions of subacute cutaneous lupus erythematosus and urticarial vasculitis in a patient with C2 deficiency. J Rheumatol 1990; 17:1222.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/144\">",
"      N&uuml;rnberg W, Grabbe J, Czarnetzki BM. Urticarial vasculitis syndrome effectively treated with dapsone and pentoxifylline. Acta Derm Venereol 1995; 75:54.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/145\">",
"      Leslie KS, Gaffney K, Ross CN, et al. A near fatal case of the dapsone hypersensitivity syndrome in a patient with urticarial vasculitis. Clin Exp Dermatol 2003; 28:496.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/146\">",
"      Ash-Bernal R, Wise R, Wright SM. Acquired methemoglobinemia: a retrospective series of 138 cases at 2 teaching hospitals. Medicine (Baltimore) 2004; 83:265.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/147\">",
"      Lopez LR, Davis KC, Kohler PF, Schocket AL. The hypocomplementemic urticarial-vasculitis syndrome: therapeutic response to hydroxychloroquine. J Allergy Clin Immunol 1984; 73:600.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/148\">",
"      Werder M, Truniger B. Hypocomplementaemic urticarial vasculitis. Nephrol Dial Transplant 1997; 12:1278.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/149\">",
"      Werni R, Schwarz T, Gschnait F. Colchicine treatment of urticarial vasculitis. Dermatologica 1986; 172:36.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/150\">",
"      Wiles JC, Hansen RC, Lynch PJ. Urticarial vasculitis treated with colchicine. Arch Dermatol 1985; 121:802.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/151\">",
"      Callen JP. Colchicine is effective in controlling chronic cutaneous leukocytoclastic vasculitis. J Am Acad Dermatol 1985; 13:193.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/152\">",
"      Asherson RA, Buchanan N, Kenwright S, et al. The normocomplementemic urticarial vasculitis syndrome--report of a case and response to colchicine. Clin Exp Dermatol 1991; 16:424.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/153\">",
"      Malkinson FD. Colchicine. New uses of an old, old drug. Arch Dermatol 1982; 118:453.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/154\">",
"      Hamid S, Cruz PD Jr, Lee WM. Urticarial vasculitis caused by hepatitis C virus infection: response to interferon alfa therapy. J Am Acad Dermatol 1998; 39:278.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/155\">",
"      Misiani R, Bellavita P, Fenili D, et al. Interferon alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus. N Engl J Med 1994; 330:751.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/156\">",
"      Matteson EL. Interferon alpha 2a therapy for urticarial vasculitis with angioedema apparently following hepatitis A infection. J Rheumatol 1996; 23:382.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/157\">",
"      Ormerod AD. Urticaria. Recognition, causes and treatment. Drugs 1994; 48:717.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/158\">",
"      Moorthy AV, Pringle D. Urticaria, vasculitis, hypocomplementemia, and immune-complex glomerulonephritis. Arch Pathol Lab Med 1982; 106:68.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/159\">",
"      Ramirez G, Saba SR, Espinoza L. Hypocomplementemic vasculitis and renal involvement. Nephron 1987; 45:147.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/160\">",
"      Heckmann JM, Lambson EM, Little F, Owen EP. Thiopurine methyltransferase (TPMT) heterozygosity and enzyme activity as predictive tests for the development of azathioprine-related adverse events. J Neurol Sci 2005; 231:71.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/161\">",
"      Worm M, Muche M, Schulze P, et al. Hypocomplementaemic urticarial vasculitis: successful treatment with cyclophosphamide-dexamethasone pulse therapy. Br J Dermatol 1998; 139:704.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/162\">",
"      Goldberg JW, Lidsky MD. Cyclophosphamide-associated hepatotoxicity. South Med J 1985; 78:222.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/163\">",
"      Soma J, Sato H, Ito S, Saito T. Nephrotic syndrome associated with hypocomplementaemic urticarial vasculitis syndrome: successful treatment with cyclosporin A. Nephrol Dial Transplant 1999; 14:1753.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/164\">",
"      Tejani AT, Butt K, Trachtman H, et al. Cyclosporine A induced remission of relapsing nephrotic syndrome in children. Kidney Int 1988; 33:729.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/165\">",
"      Worm M, Sterry W, Kolde G. Mycophenolate mofetil is effective for maintenance therapy of hypocomplementaemic urticarial vasculitis. Br J Dermatol 2000; 143:1324.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/166\">",
"      Stack PS. Methotrexate for urticarial vasculitis. Ann Allergy 1994; 72:36.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/167\">",
"      Borcea A, Greaves MW. Methotrexate-induced exacerbation of urticarial vasculitis: an unusual adverse reaction. Br J Dermatol 2000; 143:203.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/168\">",
"      Grimbert P, Schulte K, Buisson C, et al. Renal transplantation in a patient with hypocomplementemic urticarial vasculitis syndrome. Am J Kidney Dis 2001; 37:144.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/169\">",
"      Mukhtyar C, Misbah S, Wilkinson J, Wordsworth P. Refractory urticarial vasculitis responsive to anti-B-cell therapy. Br J Dermatol 2009; 160:470.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/170\">",
"      Mallipeddi R, Grattan CE. Lack of response of severe steroid-dependent chronic urticaria to rituximab. Clin Exp Dermatol 2007; 32:333.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/171\">",
"      Berkman SA, Lee ML, Gale RP. Clinical uses of intravenous immunoglobulins. Ann Intern Med 1990; 112:278.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/172\">",
"      Yamazaki-Nakashimada MA, Duran-McKinster C, Ram&iacute;rez-Vargas N, Hernandez-Bautista V. Intravenous immunoglobulin therapy for hypocomplementemic urticarial vasculitis associated with systemic lupus erythematosus in a child. Pediatr Dermatol 2009; 26:445.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/173\">",
"      Demitsu T, Yoneda K, Iida E, et al. Urticarial vasculitis with haemorrhagic vesicles successfully treated with reserpine. J Eur Acad Dermatol Venereol 2008; 22:1006.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/60/32714/abstract/174\">",
"      Epstein MM, Watsky KL, Lanzi RA. The role of diet in the treatment of a patient with urticaria and urticarial vasculitis. J Allergy Clin Immunol 1992; 90:414.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 8218 Version 8.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-190.111.122.2-14B9D587E9-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_60_32714=[""].join("\n");
var outline_f31_60_32714=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H49\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      TERMINOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Hypocomplementemic urticarial vasculitis syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Hypocomplementemic urticarial vasculitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      SYNDROMES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      AHA syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Schnitzler's syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Cogan's syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Muckle-Wells syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      PATHOPHYSIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      HISTOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Immunofluorescence",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      CLINICAL PRESENTATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Dermatologic findings",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Systemic symptoms",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Musculoskeletal",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Renal",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      - Pulmonary",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      - Gastrointestinal",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      - Other systems",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      LABORATORY FINDINGS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Erythrocyte sedimentation rate",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Hypocomplementemia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Antinuclear antibodies",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      Other laboratory tests",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      ASSOCIATED CONDITIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      Lupus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      Sj&ouml;gren's syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      Medication use",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H31\">",
"      Infections",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H32\">",
"      Serum sickness",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H33\">",
"      Complement disorders",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H34\">",
"      Malignancy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H35\">",
"      Miscellaneous",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H36\">",
"      DIAGNOSTIC APPROACH",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H37\">",
"      History",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H38\">",
"      Physical examination",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H39\">",
"      Skin biopsy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H40\">",
"      Laboratory studies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H41\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H42\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H43\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H44\">",
"      Cutaneous disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H45\">",
"      Systemic disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H46\">",
"      Severe or refractory systemic disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H47\">",
"      Other therapies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H48\">",
"      PROGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H49\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H50\">",
"      Presentation and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H51\">",
"      Treatment recommendations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"RHEUM/8218\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"RHEUM/8218|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?22/4/22594\" title=\"picture 1\">",
"      Immunofluorescence findings I",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?6/22/6498\" title=\"picture 2\">",
"      Immunofluorescence findings II",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?35/25/36240\" title=\"picture 3A\">",
"      UV lesions I",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?9/45/9939\" title=\"picture 3B\">",
"      UV lesions III",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?38/53/39760\" title=\"picture 4\">",
"      UV lesions II",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?8/57/9108\" title=\"picture 5\">",
"      UV lesions IV",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?28/47/29424\" title=\"picture 6\">",
"      UV lesions V",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?39/21/40273\" title=\"picture 7\">",
"      Diascopy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"RHEUM/8218|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?18/10/18603\" title=\"table 1\">",
"      Diagnostic criteria HUVS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?7/47/7931\" title=\"table 2\">",
"      Cutaneous features",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?1/52/1868\" title=\"table 3\">",
"      Clinical features UV",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?9/46/9964\" title=\"table 4\">",
"      Conditions assoc UV HUVS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?1/56/1932\" title=\"table 5\">",
"      Treatment UV HUVS",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?25/20/25927?source=related_link\">",
"      Acquired C1 inhibitor deficiency: Management and prognosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/9/43161?source=related_link\">",
"      Antimalarial drugs in the treatment of rheumatic disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/19/30010?source=related_link\">",
"      Chronic urticaria: Clinical manifestations, diagnosis, pathogenesis, and natural history",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?0/7/117?source=related_link\">",
"      Chronic urticaria: Standard management and patient education",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?12/42/12968?source=related_link\">",
"      Cogan&rsquo;s syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?23/58/24487?source=related_link\">",
"      Cryopyrin-associated periodic syndromes and related disorders",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?0/5/80?source=related_link\">",
"      Episcleritis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/57/30614?source=related_link\">",
"      Hypersensitivity vasculitis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?41/58/42920?source=related_link\">",
"      Inherited disorders of the complement system",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?10/25/10647?source=related_link\">",
"      Overview and clinical assessment of the complement system",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?8/40/8842?source=related_link\">",
"      Serum sickness and serum sickness-like reactions",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f31_60_32715="Emesis pt risk factors";
var content_f31_60_32715=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F81948&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F81948&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Individual risk factors for radiotherapy emetogenicity",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1\" colspan=\"2\">",
"       Risk factor",
"      </td>",
"      <td class=\"subtitle1\">",
"       Risk score",
"      </td>",
"     </tr>",
"     <tr>",
"      <td rowspan=\"2\">",
"       Age",
"      </td>",
"      <td>",
"       &gt;55 years",
"      </td>",
"      <td>",
"       0",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       &lt;55 years",
"      </td>",
"      <td>",
"       1",
"      </td>",
"     </tr>",
"     <tr>",
"      <td rowspan=\"2\">",
"       Sex",
"      </td>",
"      <td>",
"       Male",
"      </td>",
"      <td>",
"       1",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Female",
"      </td>",
"      <td>",
"       2",
"      </td>",
"     </tr>",
"     <tr>",
"      <td rowspan=\"2\">",
"       Alcohol consumption",
"      </td>",
"      <td>",
"       Yes (&gt;100 g/day)",
"      </td>",
"      <td>",
"       0",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       No",
"      </td>",
"      <td>",
"       1",
"      </td>",
"     </tr>",
"     <tr>",
"      <td rowspan=\"2\">",
"       Previous N&amp;V;",
"      </td>",
"      <td>",
"       Yes",
"      </td>",
"      <td>",
"       1",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       No",
"      </td>",
"      <td>",
"       0",
"      </td>",
"     </tr>",
"     <tr>",
"      <td rowspan=\"2\">",
"       Anxiety",
"      </td>",
"      <td>",
"       Yes",
"      </td>",
"      <td>",
"       1",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       No",
"      </td>",
"      <td>",
"       0",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       <strong>",
"        Risk profile; 4 = normal risk, 5-6 = high risk",
"       </strong>",
"      </td>",
"      <td>",
"       &nbsp;",
"      </td>",
"      <td>",
"       &nbsp;",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from: Feyer, P. Acta Oncol 2004; 43 Suppl 15:5, and Feyer P, et al. Support Cancer Care 2005; 13:122.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_60_32715=[""].join("\n");
var outline_f31_60_32715=null;
var title_f31_60_32716="Causes polyarticular joint pain";
var content_f31_60_32716=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F74266&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F74266&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Major causes of inflammatory polyarticular rheumatism",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\" class=\"container\">",
"     <tr>",
"      <td class=\"container\">",
"       <table cellspacing=\"0\">",
"        <tr>",
"         <td class=\"subtitle1_single\">",
"          Infectious arthritis",
"         </td>",
"        </tr>",
"        <tr>",
"         <td class=\"sublist1_start\">",
"          Bacterial",
"         </td>",
"        </tr>",
"        <tr>",
"         <td class=\"sublist1\">",
"          Lyme disease",
"         </td>",
"        </tr>",
"        <tr>",
"         <td class=\"sublist1\">",
"          Bacterial endocarditis",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Viral",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Other infections",
"         </td>",
"        </tr>",
"        <tr>",
"         <td class=\"subtitle1_single\">",
"          Postinfectious (reactive) arthritis",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Rheumatic fever",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Reactive arthritis",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Enteric infection",
"         </td>",
"        </tr>",
"        <tr>",
"         <td class=\"subtitle1_single\">",
"          Other seronegative spondyloarthritides",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Ankylosing spondylitis",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Psoriatic arthritis",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Inflammatory bowel disease",
"         </td>",
"        </tr>",
"        <tr>",
"         <td class=\"subtitle1_single\">",
"          Rheumatoid arthritis",
"         </td>",
"        </tr>",
"        <tr>",
"         <td class=\"subtitle1_single\">",
"          Inflammatory osteoarthritis",
"         </td>",
"        </tr>",
"       </table>",
"      </td>",
"      <td class=\"container\">",
"       <table cellspacing=\"0\">",
"        <tr>",
"         <td class=\"subtitle1_single\">",
"          Crystal-induced arthritis",
"         </td>",
"        </tr>",
"        <tr>",
"         <td class=\"subtitle1_single\">",
"          Systemic rheumatic illnesses",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Systemic lupus erythematosus",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Systemic vasculitis",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Systemic sclerosis",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Polymyositis/dermatomyositis",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Still's disease",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Behcet syndrome",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Relapsing polychondritis",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Autoinflammatory disorders",
"         </td>",
"        </tr>",
"        <tr>",
"         <td class=\"subtitle1_single\">",
"          Other systemic illnesses",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Sarcoidosis",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Palindromic rheumatism",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Familial Mediterranean fever",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Malignancy",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Hyperlipoproteinemias",
"         </td>",
"        </tr>",
"       </table>",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_60_32716=[""].join("\n");
var outline_f31_60_32716=null;
var title_f31_60_32717="Paraneoplastic antibodies";
var content_f31_60_32717=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F77919&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F77919&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Antibodies, paraneoplastic syndromes and associated cancers",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Antibody",
"       </td>",
"       <td class=\"subtitle1\">",
"        Syndrome",
"       </td>",
"       <td class=\"subtitle1\">",
"        Associated cancers",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"3\">",
"        Well characterized paraneoplastic antibodies*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Anti-Hu (ANNA-1)",
"       </td>",
"       <td>",
"        Encephalomyelitis including cortical, limbic, brainstem encephalitis, cerebellar degeneration, myelitis, sensory neuronopathy, and/or autonomic dysfunction",
"       </td>",
"       <td>",
"        SCLC, other",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Anti-Yo (PCA-1)",
"       </td>",
"       <td>",
"        Cerebellar degeneration",
"       </td>",
"       <td>",
"        Gynecological, breast",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Anti-Ri (ANNA-2)",
"       </td>",
"       <td>",
"        Cerebellar degeneration, brainstem encephalitis, opsoclonus-myoclonus",
"       </td>",
"       <td>",
"        Breast, gynecological, SCLC",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Anti-Tr",
"       </td>",
"       <td>",
"        Cerebellar degeneration",
"       </td>",
"       <td>",
"        Hodgkin's lymphoma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Anti-CV2/CRMP5",
"       </td>",
"       <td>",
"        Encephalomyelitis, cerebellar degeneration, chorea, peripheral neuropathy",
"       </td>",
"       <td>",
"        SCLC, thymoma, other",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Anti-Ma proteins&bull; (Ma1, Ma2)",
"       </td>",
"       <td>",
"        Limbic, hypothalamic, brainstem encephalitis (infrequently cerebellar degeneration)",
"       </td>",
"       <td>",
"        Germ-cell tumors of testis, lung cancer, other solid tumors",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Anti-amphiphysin",
"       </td>",
"       <td>",
"        Stiff-person syndrome, encephalomyelitis",
"       </td>",
"       <td>",
"        Breast, lung cancer",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Anti-recoverin&Delta;",
"       </td>",
"       <td>",
"        Cancer-associated retinopathy (CAR)",
"       </td>",
"       <td>",
"        SCLC",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"3\">",
"        Partially-characterized paraneoplastic antibodies*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Anti-Zic 4",
"       </td>",
"       <td>",
"        Cerebellar degeneration",
"       </td>",
"       <td>",
"        SCLC",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        mGluR1",
"       </td>",
"       <td>",
"        Cerebellar degeneration",
"       </td>",
"       <td>",
"        No tumor or Hodgkin's lymphoma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        ANNA-3",
"       </td>",
"       <td>",
"        Sensory neuronopathy, encephalomyelitis",
"       </td>",
"       <td>",
"        SCLC",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        PCA2",
"       </td>",
"       <td>",
"        Encephalomyelitis, cerebellar degeneration",
"       </td>",
"       <td>",
"        SCLC",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Anti-bipolar cells of the retina",
"       </td>",
"       <td>",
"        Melanoma-associated retinopathy (MAR)",
"       </td>",
"       <td>",
"        Melanoma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"3\">",
"        Antibodies that occur with and without cancer association",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Anti-VGCC",
"       </td>",
"       <td>",
"        Lambert-Eaton myasthenic syndrome, cerebellar dysfunction",
"       </td>",
"       <td>",
"        SCLC",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Anti-AChR",
"       </td>",
"       <td>",
"        Myasthenia gravis",
"       </td>",
"       <td>",
"        Thymoma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Anti-NMDAR",
"       </td>",
"       <td>",
"        Multistage syndrome with memory and behavioral disturbances, psychosis, seizures, dyskinesias, and autonomic dysfunction",
"       </td>",
"       <td>",
"        Teratoma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Anti-AMPAR",
"       </td>",
"       <td>",
"        Limbic encephalitis, psychiatric disturbances",
"       </td>",
"       <td>",
"        Variable solid tumors",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Anti-GABA(B) receptor",
"       </td>",
"       <td>",
"        Seizures, limbic encephalitis",
"       </td>",
"       <td>",
"        SCLC",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Anti-LGI1 (previously attributed to VGKC)",
"       </td>",
"       <td>",
"        Limbic encephalitis, seizures",
"       </td>",
"       <td>",
"        Thymoma, SCLC",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Anti-CASPR2 (previously attributed to VGKC)",
"       </td>",
"       <td>",
"        Morvan's syndrome and some patients with neuromyotonia",
"       </td>",
"       <td>",
"        Thymoma and variable solid tumors",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Anti-nAChR",
"       </td>",
"       <td>",
"        Subacute pandysautonomia",
"       </td>",
"       <td>",
"        SCLC, others",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        GlyR",
"       </td>",
"       <td>",
"        Encephalomyelitis with muscle spasms, rigidity, myoclonus, hyperekplexia",
"       </td>",
"       <td>",
"        Often without cancer",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     PCA: Purkinje cell antibody; ANNA: antineuronal-nuclear antibody; VGCC: voltage-gated calcium channel; VGKC: voltage-gated potassium channel; nAChR: neuronal acetyl-choline receptor.",
"     <br>",
"      * Well-characterized antibodies are those directed against antigens whose molecular identity is known, or that have been identified by several investigators. (Graus F, et al. J Neurol Neurosurg Psychiatry 2004; 75:1135.)",
"      <br>",
"       <span class=\"bullet\">",
"        &bull;",
"       </span>",
"       Antibodies to Ma2: younger than 45 years, usually men with testicular germ-cell tumors; older than 45, men or women with lung cancer and less frequently other tumors. Ma1 antibodies often associated with tumors other than germ-cell neoplasms and confers a worse prognosis, with more prominent brainstem and cerebellar dysfunction.",
"       <br>",
"        &Delta; Other antibodies reported in a few or isolated cases include antibodies to tubby-like protein and the photoreceptor-specific nuclear receptor.",
"       </br>",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_60_32717=[""].join("\n");
var outline_f31_60_32717=null;
var title_f31_60_32718="Metabolism of mifepristone";
var content_f31_60_32718=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ENDO%2F64721&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ENDO%2F64721&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 522px\">",
"   <div class=\"ttl\">",
"    Metabolism of mifepristone",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 502px; height: 502px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_60_32718=[""].join("\n");
var outline_f31_60_32718=null;
var title_f31_60_32719="TEE pulmonic valve and pulmonary artery";
var content_f31_60_32719=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F57980&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F57980&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 529px\">",
"   <div class=\"ttl\">",
"    Pulmonic valve and pulmonary arteries on transesophageal echocardiogram",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 509px; height: 214px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Panel A: Vertical (90&ordm;) imaging plane shows the pulmonic valve (PV), main pulmonary artery (PA), and the right (RPA) and left pulmonary arteries (LPA). Panel B: With further anterior rotation (panel B), the right ventricle (RV), tricuspid valve (TV), right (RA) and left atria (LA), interatrial septum, and aortic valve (AoV) are well seen.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Warren Manning, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_60_32719=[""].join("\n");
var outline_f31_60_32719=null;
